{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:08:12Z","timestamp":1790039292223,"version":"4.0.1"},"reference-count":321,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10568-1","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T02:47:33Z","timestamp":1760669253000},"page":"1559-1589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Special topics: heart failure\u2013related cardiogenic shock, valvular heart disease and end-stage renal disease. Part 4 of the International Expert Opinion Series on Acute Heart Failure Management"],"prefix":"10.1007","volume":"30","author":[{"given":"Matteo","family":"Pagnesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivna G. C. V.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Ambrosy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edimar A.","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastase","family":"Dzudie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonathan","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivadasanpillai","family":"Harikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d2scar","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika S.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti E.","family":"Nauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sliwa-Hahnle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"10568_CR1","volume":"10","author":"M Osman","year":"2021","unstructured":"Osman M, Syed M, Patibandla S, Sulaiman S, Kheiri B, Shah MK, Bianco C, Balla S, Patel B (2021) Fifteen-year trends in incidence of cardiogenic shock hospitalization and in-hospital mortality in the United States. J Am Heart Assoc 10:e021061","journal-title":"J Am Heart Assoc"},{"key":"10568_CR2","volume":"12","author":"DD Berg","year":"2019","unstructured":"Berg DD, Bohula EA, van Diepen S, Katz JN, Alviar CL, Baird-Zars VM, Barnett CF, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis AP, Haleem A, Hollenberg SM, Horowitz JM, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Ng J, Orgel R, Overgaard CB, Park J-G, Phreaner N, Roswell RO, Schulman SP, Jeffrey Snell R, Solomon MA, Ternus B, Tymchak W, Vikram F, Morrow DA (2019) Epidemiology of shock in contemporary cardiac intensive care units. Circ Cardiovasc Qual Outcomes 12:e005618","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10568_CR3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2020.10.054","volume":"232","author":"JC Jentzer","year":"2021","unstructured":"Jentzer JC, Ahmed AM, Vallabhajosyula S, Burstein B, Tabi M, Barsness GW, Murphy JG, Best PJ, Bell MR (2021) Shock in the cardiac intensive care unit: changes in epidemiology and prognosis over time. Am Heart J 232:94\u2013104","journal-title":"Am Heart J"},{"key":"10568_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.acvd.2024.07.059","volume":"117","author":"D Sulman","year":"2024","unstructured":"Sulman D, Beaupr\u00e9 F, Devos P, Procopi N, Kerneis M, Guedeney P, Barth\u00e9l\u00e9my O, Elhadad A, Rouanet S, Brugier D, Hekimian G, Chommeloux J, Combes A, Silvain J, Collet J-P, Montalescot G, Zeitouni M (2024) Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort. Arch Cardiovasc Dis 117:569\u2013576","journal-title":"Arch Cardiovasc Dis"},{"key":"10568_CR5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ehf2.13734","volume":"9","author":"C Delmas","year":"2022","unstructured":"Delmas C, Roubille F, Lamblin N, Bonello L, Leurent G, Levy B, Elbaz M, Danchin N, Champion S, Lim P, Schneider F, Cariou A, Khachab H, Bourenne J, Seronde M, Schurtz G, Harbaoui B, Vanzetto G, Quentin C, Delabranche X, Aissaoui N, Combaret N, Manzo-Silberman S, Tomasevic D, Marchandot B, Lattuca B, Henry P, Gerbaud E, Bonnefoy E, Puymirat E (2022) Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry. ESC Heart Fail 9:408\u2013419","journal-title":"ESC Heart Fail"},{"key":"10568_CR6","first-page":"768","volume":"13","author":"T Guido","year":"2024","unstructured":"Guido T, Giovanni T, Elena G, Anna Z, Michele Z, Stefano F (2024) Cardiogenic shock in general intensive care unit: a nationwide prospective analysis of epidemiology and outcome. European Heart Journal: Acute Cardiovascular Care 13:768\u2013778","journal-title":"European Heart Journal: Acute Cardiovascular Care"},{"key":"10568_CR7","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/ejhf.3333","volume":"26","author":"KH Choi","year":"2024","unstructured":"Choi KH, Kang D, Park H, Park TK, Lee JM, Song YB, Hahn J, Choi S, Gwon H, Cho J, Yang JH (2024) In-hospital and long-term outcomes of cardiogenic shock complicating myocardial infarction versus heart failure. Eur J Heart Fail 26:1594\u20131603","journal-title":"Eur J Heart Fail"},{"key":"10568_CR8","doi-asserted-by":"crossref","unstructured":"Kyriakopoulos CP, Sideris K, Taleb I, Maneta E, Hamouche R, Tseliou E, Zhang C, Presson AP, Dranow E, Shah KS, Jones TL, Fang JC, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos SG (2024) Clinical characteristics and outcomes of patients suffering acute decompensated heart failure complicated by cardiogenic shock. Circ Heart Fail 17","DOI":"10.1161\/CIRCHEARTFAILURE.123.011358"},{"key":"10568_CR9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cardfail.2023.09.003","volume":"30","author":"AR Garan","year":"2024","unstructured":"Garan AR, Kataria R, Li B, Sinha S, Kanwar MK, Hernandez-Montfort J, Li S, Ton V-K, Blumer V, Grandin EW, Harwani N, Zazzali P, Walec KD, Hickey G, Abraham J, Mahr C, Nathan S, Vorovich E, Guglin M, Hall S, Khalife W, Sangal P, Zhang Y, Kim JH, Schwartzman A, Vishnevsky A, Burkhoff D, Kapur NK (2024) Outcomes of patients transferred to tertiary care centers for treatment of cardiogenic shock: a cardiogenic shock working group analysis. J Card Fail 30:564\u2013575","journal-title":"J Card Fail"},{"key":"10568_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9040931","author":"B Schrage","year":"2020","unstructured":"Schrage B, Weimann J, Dabboura S, Yan I, Hilal R, Becher PM, Seiffert M, Bernhardt AM, Kluge S, Reichenspurner H, Blankenberg S, Westermann D (2020) Patient characteristics, treatment and outcome in non-ischemic vs. ischemic cardiogenic shock. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9040931","journal-title":"J Clin Med"},{"key":"10568_CR11","doi-asserted-by":"crossref","unstructured":"Schrage B, Dabboura S, Yan I, Hilal R, Neumann JT, S\u00f6rensen NA, Go\u00dfling A, Becher PM, Grahn H, Wagner T, Seiffert M, Kluge S, Reichenspurner H, Blankenberg S, Westermann D (2020) Application of the SCAI classification in a cohort of patients with cardiogenic shock. Catheter Cardiovasc Interv 96.","DOI":"10.1002\/ccd.28707"},{"key":"10568_CR12","first-page":"1339","volume":"96","author":"DA Baran","year":"2020","unstructured":"Baran DA, Long A, Badiye AP, Stelling K (2020) Prospective validation of the SCAI shock classification: single center analysis. Catheter Cardiovasc Interv 96:1339\u20131347","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR13","doi-asserted-by":"crossref","unstructured":"Sinha SS, Rosner CM, Tehrani BN, Maini A, Truesdell AG, Lee S Ben, Bagchi P, Cameron J, Damluji AA, Desai M, Desai SS, Epps KC, deFilippi C, Flanagan MC, Genovese L, Moukhachen H, Park JJ, Psotka MA, Raja A, Shah P, Sherwood MW, Singh R, Tang D, Young KD, Welch T, O\u2019Connor CM, Batchelor WB (2022) Cardiogenic shock from heart failure versus acute myocardial infarction: clinical characteristics, hospital course, and 1-year outcomes. Circ Heart Fail 15","DOI":"10.1161\/CIRCHEARTFAILURE.121.009279"},{"key":"10568_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099","author":"KL Thayer","year":"2020","unstructured":"Thayer KL, Zweck E, Ayouty M, Garan AR, Hernandez-Montfort J, Mahr C, Morine KJ, Newman S, Jorde L, Haywood JL, Harwani NM, Esposito ML, Davila CD, Wencker D, Sinha SS, Vorovich E, Abraham J, O\u2019Neill W, Udelson J, Burkhoff D, Kapur NK (2020) Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock. Circ Heart Fail. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007099","journal-title":"Circ Heart Fail"},{"key":"10568_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.hjc.2022.11.001","volume":"69","author":"MI Barrionuevo-S\u00e1nchez","year":"2023","unstructured":"Barrionuevo-S\u00e1nchez MI, Ariza-Sol\u00e9 A, Del PN, Garc\u00eda M, S\u00e1nchez-Salado JC, Lorente V, Alegre O, Lla\u00f3 I, Bernal JL, Fern\u00e1ndez-P\u00e9rez C, Galv\u00e1n-Rom\u00e1n F, de la Cuerda F, Pascual J, Cequier A, Comin-Colet J, Elola FJ (2023) Impact of shock aetiology and hospital characteristics on the clinical profile, management and prognosis of patients with non ACS-related cardiogenic shock. Hellenic J Cardiol 69:16\u201323","journal-title":"Hellenic J Cardiol"},{"key":"10568_CR16","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","volume":"74","author":"JC Jentzer","year":"2019","unstructured":"Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA (2019) Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol 74:2117\u20132128","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR17","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1002\/ehf2.14510","volume":"10","author":"M Bertaina","year":"2023","unstructured":"Bertaina M, Morici N, Frea S, Garatti L, Briani M, Sorini C, Villanova L, Corrada E, Sacco A, Moltrasio M, Ravera A, Tedeschi M, Bertoldi L, Lettino M, Saia F, Corsini A, Camporotondo R, Colombo CNJ, Bertolin S, Rota M, Oliva F, Iannaccone M, Valente S, Pagnesi M, Metra M, Sionis A, Marini M, De FGM, Kapur NK, Pappalardo F, Tavazzi G (2023) Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction. ESC Heart Fail 10:3472\u20133482","journal-title":"ESC Heart Fail"},{"key":"10568_CR18","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ehf2.15148","volume":"12","author":"C Garc\u00eda-Garc\u00eda","year":"2025","unstructured":"Garc\u00eda-Garc\u00eda C, L\u00f3pez-Sobrino T, Sanz-Girgas E, Cueto MR, Aboal J, Pastor P, Buera I, Sionis A, Andrea R, Rodr\u00edguez-L\u00f3pez J, S\u00e1nchez-Salado JC, Tomas C, Ba\u00f1eras J, Ariza A, Lup\u00f3n J, Bay\u00e9s-Gen\u00eds A, Rueda F, Grup de Treball de Cures Agudes Cardiol\u00f2giques Societat Catalana de Cardiologia (2025) Cardiogenic shock mortality according to aetiology in a Mediterranean cohort: results from the Shock-CAT study. ESC Heart Fail 12:1336\u20131345","journal-title":"ESC Heart Fail"},{"key":"10568_CR19","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ehf2.14596","volume":"11","author":"S Soussi","year":"2024","unstructured":"Soussi S, Ahmadiankalati M, Jentzer JC, Marshall JC, Lawler PR, Herridge M, Mebazaa A, Gayat E, Lu Z, Dos Santos CC, French and European Outcome Registry in Intensive Care Units (FROG\u2010ICU) and CCCTBG trans\u2010trial group study for InFACT \u2013 the International Forum for Acute Care Trialists (2024) Clinical phenotypes of cardiogenic shock survivors: insights into late host responses and long-term outcomes. ESC Heart Fail 11:1242\u20131248","journal-title":"ESC Heart Fail"},{"key":"10568_CR20","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cardfail.2021.08.010","volume":"27","author":"J Abraham","year":"2021","unstructured":"Abraham J, Blumer V, Burkhoff D, Pahuja M, Sinha SS, Rosner C, Vorovich E, Grafton G, Bagnola A, Hernandez-Montfort JA, Kapur NK (2021) Heart failure-related cardiogenic shock: pathophysiology, evaluation and management considerations: review of heart failure-related cardiogenic shock. J Card Fail 27:1126\u20131140","journal-title":"J Card Fail"},{"key":"10568_CR21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cardfail.2021.08.014","volume":"27","author":"AS Bhatt","year":"2021","unstructured":"Bhatt AS, Berg DD, Bohula EA, Alviar CL, Baird-Zars VM, Barnett CF, Burke JA, Carnicelli AP, Chaudhry S-P, Daniels LB, Fang JC, Fordyce CB, Gerber DA, Guo J, Jentzer JC, Katz JN, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Nativi-Nicolau J, Phreaner N, Roswell RO, Sinha SS, Jeffrey Snell R, Solomon MA, Van DS, Morrow DA (2021) De novo vs acute-on-chronic presentations of heart failure-related cardiogenic shock: insights from the Critical Care Cardiology Trials Network Registry. J Card Fail 27:1073\u20131081","journal-title":"J Card Fail"},{"key":"10568_CR22","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ehf2.12670","volume":"7","author":"TL Jones","year":"2020","unstructured":"Jones TL, Tan MC, Nguyen V, Kearney KE, Maynard CC, Anderson E, Mahr C, McCabe JM (2020) Outcome differences in acute vs. acute on chronic heart failure and cardiogenic shock. ESC Heart Fail 7:1118\u20131124","journal-title":"ESC Heart Fail"},{"key":"10568_CR23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijcard.2023.04.041","volume":"384","author":"NSV Singam","year":"2023","unstructured":"Singam NSV, Tabi M, Wiley B, Anavekar N, Jentzer J (2023) Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure. Int J Cardiol 384:38\u201347","journal-title":"Int J Cardiol"},{"key":"10568_CR24","doi-asserted-by":"crossref","first-page":"103013","DOI":"10.1016\/j.eclinm.2024.103013","volume":"79","author":"S Soussi","year":"2025","unstructured":"Soussi S, Tarvasm\u00e4ki T, Kimmoun A, Ahmadiankalati M, Azibani F, dos Santos CC, Duarte K, Gayat E, Jentzer JC, Harjola V-P, Hibbert B, Jung C, Johan L, Levy B, Lu Z, Lawler PR, Marshall JC, P\u00f6ss J, Sadoune M, Nguyen A, Raynor A, Peoc\u2019h K, Thiele H, Mathew R, Mebazaa A (2025) Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trials. EClinicalMedicine 79:103013","journal-title":"EClinicalMedicine"},{"key":"10568_CR25","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2025.2163","volume":"333","author":"EE Moin","year":"2025","unstructured":"Moin EE, Seewald NJ, Halpern SD (2025) Use of life support and outcomes among patients admitted to intensive care units. JAMA 333:1793\u20131803","journal-title":"JAMA"},{"key":"10568_CR26","doi-asserted-by":"crossref","unstructured":"Kimmoun A, O\u2019Brien C, Blumer V, Wenzl FA, P\u00f6ss J, Zeymer U, M\u00f8ller JE, Aissaoui N, Sinha SS, Combes A, Sato N, Sionis A, Soussi S, Price S, Monroe RE, Mathew R, Mebazaa A (2025) Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists Workshop. Lancet Respir Med","DOI":"10.1016\/S2213-2600(25)00084-0"},{"key":"10568_CR27","first-page":"29","volume":"94","author":"DA Baran","year":"2019","unstructured":"Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O\u2019Neill W, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS (2019) SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 94:29\u201337","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR28","doi-asserted-by":"crossref","unstructured":"Diepen S van, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG (2017) Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 136","DOI":"10.1161\/CIR.0000000000000525"},{"issue":"9","key":"10568_CR29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"SS Naidu","year":"2022","unstructured":"Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, Grines CL, Diercks DB, Hall S, Kapur NK, Kent W, Rao SV, Samsky MD, Thiele H, Truesdell AG, Henry TD (2022) SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies. J Am Coll Cardiol 79(9):933\u2013946","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR30","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","volume":"22","author":"O Chioncel","year":"2020","unstructured":"Chioncel O, Parissis J, Mebazaa A, Thiele H, Desch S, Bauersachs J, Harjola V-P, Antohi E-L, Arrigo M, Ben GT, Celutkiene J, Collins SP, DeBacker D, Iliescu VA, Jankowska E, Jaarsma T, Keramida K, Lainscak M, Lund LH, Lyon AR, Masip J, Metra M, Miro O, Mortara A, Mueller C, Mullens W, Nikolaou M, Piepoli M, Price S, Rosano G, Vieillard-Baron A, Weinstein JM, Anker SD, Filippatos G, Ruschitzka F, Coats AJS, Seferovic P (2020) Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 22:1315\u20131341","journal-title":"Eur J Heart Fail"},{"key":"10568_CR31","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force Members, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJ V, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, ESC Scientific Document Group (2022) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 24:4\u2013131","DOI":"10.1002\/ejhf.2333"},{"key":"10568_CR32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijcard.2018.06.036","volume":"270","author":"M Shah","year":"2018","unstructured":"Shah M, Patel B, Tripathi B, Agarwal M, Patnaik S, Ram P, Patil S, Shin J, Jorde UP (2018) Hospital mortality and thirty day readmission among patients with non-acute myocardial infarction related cardiogenic shock. Int J Cardiol 270:60\u201367","journal-title":"Int J Cardiol"},{"key":"10568_CR33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2019.03.015","volume":"213","author":"S Yandrapalli","year":"2019","unstructured":"Yandrapalli S, Sanaani A, Harikrishnan P, Aronow WS, Frishman WH, Lanier GM, Ahmed A, Fonarow GC (2019) Cardiogenic shock during heart failure hospitalizations: age-, sex-, and race-stratified trends in incidence and outcomes. Am Heart J 213:18\u201329","journal-title":"Am Heart J"},{"key":"10568_CR34","doi-asserted-by":"crossref","unstructured":"Hernandez-Montfort J, Sinha SS, Thayer KL, Whitehead EH, Pahuja M, Garan AR, Mahr C, Haywood JL, Harwani NM, Schaeffer A, Wencker D, Kanwar M, Vorovich E, Abraham J, Burkhoff D, Kapur NK (2021) Clinical outcomes associated with acute mechanical circulatory support utilization in heart failure related cardiogenic shock. Circ Heart Fail 14","DOI":"10.1161\/CIRCHEARTFAILURE.120.007924"},{"key":"10568_CR35","first-page":"176","volume":"11","author":"J Hernandez-Montfort","year":"2023","unstructured":"Hernandez-Montfort J, Kanwar M, Sinha SS, Garan AR, Blumer V, Kataria R, Whitehead EH, Yin M, Li B, Zhang Y, Thayer KL, Baca P, Dieng F, Harwani NM, Guglin M, Abraham J, Hickey G, Nathan S, Wencker D, Hall S, Schwartzman A, Khalife W, Li S, Mahr C, Kim J, Vorovich E, Pahuja M, Burkhoff D, Kapur NK (2023) Clinical presentation and in-hospital trajectory of heart failure and cardiogenic shock. JACC: Heart Failure 11:176\u2013187","journal-title":"JACC: Heart Failure"},{"key":"10568_CR36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ejhf.3082","volume":"26","author":"J Sundermeyer","year":"2024","unstructured":"Sundermeyer J, Kellner C, Beer BN, Besch L, Dettling A, Bertoldi LF, Blankenberg S, Dauw J, Dindane Z, Eckner D, Eitel I, Graf T, Horn P, Jozwiak-Nozdrzykowska J, Kirchhof P, Kluge S, Linke A, Landmesser U, Luedike P, L\u00fcsebrink E, Majunke N, Mangner N, Maniuc O, M\u00f6bius Winkler S, Nordbeck P, Orban M, Pappalardo F, Pauschinger M, Pazdernik M, Proudfoot A, Kelham M, Rassaf T, Reichenspurner H, Scherer C, Schulze PC, Schwinger RHG, Skurk C, Sramko M, Tavazzi G, Thiele H, Villanova L, Morici N, Winzer EB, Westermann D, Gustafsson F, Schrage B (2024) Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock. Eur J Heart Fail 26:432\u2013444","journal-title":"Eur J Heart Fail"},{"key":"10568_CR37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ejhf.2796","volume":"25","author":"B Schrage","year":"2023","unstructured":"Schrage B, Sundermeyer J, Beer BN, Bertoldi L, Bernhardt A, Blankenberg S, Dauw J, Dindane Z, Eckner D, Eitel I, Graf T, Horn P, Kirchhof P, Kluge S, Linke A, Landmesser U, Luedike P, L\u00fcsebrink E, Mangner N, Maniuc O, Winkler SM, Nordbeck P, Orban M, Pappalardo F, Pauschinger M, Pazdernik M, Proudfoot A, Kelham M, Rassaf T, Reichenspurner H, Scherer C, Schulze PC, Schwinger RHG, Skurk C, Sramko M, Tavazzi G, Thiele H, Villanova L, Morici N, Wechsler A, Westenfeld R, Winzer E, Westermann D (2023) Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock. Eur J Heart Fail 25:562\u2013572","journal-title":"Eur J Heart Fail"},{"key":"10568_CR38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009279","volume":"15","author":"SS Sinha","year":"2022","unstructured":"Sinha SS, Rosner CM, Tehrani BN, Maini A, Truesdell AG, Lee SB, Bagchi P, Cameron J, Damluji AA, Desai M, Desai SS, Epps KC, deFilippi C, Flanagan MC, Genovese L, Moukhachen H, Park JJ, Psotka MA, Raja A, Shah P, Sherwood MW, Singh R, Tang D, Young KD, Welch T, O\u2019Connor CM, Batchelor WB (2022) Cardiogenic shock from heart failure versus acute myocardial infarction: clinical characteristics, hospital course, and 1-year outcomes. Circ Heart Fail 15:e009279","journal-title":"Circ Heart Fail"},{"key":"10568_CR39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2022.04.049","volume":"80","author":"NK Kapur","year":"2022","unstructured":"Kapur NK, Kanwar M, Sinha SS, Thayer KL, Garan AR, Hernandez-Montfort J, Zhang Y, Li B, Baca P, Dieng F, Harwani NM, Abraham J, Hickey G, Nathan S, Wencker D, Hall S, Schwartzman A, Khalife W, Li S, Mahr C, Kim JH, Vorovich E, Whitehead EH, Blumer V, Burkhoff D (2022) Criteria for defining stages of cardiogenic shock severity. J Am Coll Cardiol 80:185\u2013198","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1454884","author":"M Quien","year":"2024","unstructured":"Quien M, Bae JY, Jang S-J, Davila C (2024) Short term outcomes and resource utilization in de-novo versus acute on chronic heart failure related cardiogenic shock: a nationwide analysis. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2024.1454884","journal-title":"Front Cardiovasc Med"},{"key":"10568_CR41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijcard.2023.04.049","volume":"383","author":"M Bottiroli","year":"2023","unstructured":"Bottiroli M, Calini A, Morici N, Tavazzi G, Galimberti L, Facciorusso C, Ammirati E, Russo C, Montoli A, Mondino M (2023) Acute kidney injury in patients with acute decompensated heart failure-cardiogenic shock: prevalence, risk factors and outcome. Int J Cardiol 383:42\u201349","journal-title":"Int J Cardiol"},{"key":"10568_CR42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1536\/ihj.48.195","volume":"48","author":"H Shinagawa","year":"2007","unstructured":"Shinagawa H, Inomata T, Koitabashi T, Nakano H, Takeuchi I, Osaka T, Nishii M, Takehana H, Izumi T (2007) Increased serum bilirubin levels coincident with heart failure decompensation indicate the need for intravenous inotropic agents. Int Heart J 48:195\u2013204","journal-title":"Int Heart J"},{"key":"10568_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/echo.15901","author":"M Riccardi","year":"2024","unstructured":"Riccardi M, Cani DS, Pagnesi M, Lombardi CM, Metra M, Inciardi RM (2024) Assessing aortic flow with doppler echocardiography in cardiogenic shock: a crucial diagnostic tool. Echocardiography. https:\/\/doi.org\/10.1111\/echo.15901","journal-title":"Echocardiography"},{"key":"10568_CR44","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00134-024-07590-6","volume":"50","author":"L Flower","year":"2024","unstructured":"Flower L, Waite A, Boulton A, Peck M, Akhtar W, Boyle AJ, Gudibande S, Ingram TE, Johnston B, Marsh S, Miller A, Nash A, Olusanya O, Parulekar P, Wagstaff D, Wilkinson J, Proudfoot AG, NEAT ECHO Collaborators (2024) The use of echocardiography in the management of shock in critical care: a prospective, multi-centre, observational study. Intensive Care Med 50:1668\u20131680","journal-title":"Intensive Care Med"},{"key":"10568_CR45","first-page":"646","volume":"13","author":"S Frea","year":"2024","unstructured":"Frea S, Gravinese C, Boretto P, Lio GD, Bocchino PP, Angelini F, Cingolani M, Gallone G, Montefusco A, Valente E, Pidello S, Raineri C, Ferrari GMD (2024) Comprehensive non-invasive haemodynamic assessment in acute decompensated heart failure-related cardiogenic shock: a step towards echodynamics. European Heart Journal: Acute Cardiovascular Care 13:646\u2013655","journal-title":"European Heart Journal: Acute Cardiovascular Care"},{"key":"10568_CR46","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0735-1097(01)01651-5","volume":"38","author":"CH Chen","year":"2001","unstructured":"Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA, Kawaguchi M, Kass DA (2001) Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 38:2028\u20132034","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR47","first-page":"313","volume":"26","author":"MR Pinsky","year":"2020","unstructured":"Pinsky MR, Guarracino F (2020) How to assess ventriculoarterial coupling in sepsis. Curr Opin Crit Care 26:313\u2013318","journal-title":"Curr Opin Crit Care"},{"key":"10568_CR48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.amjcard.2023.08.118","volume":"207","author":"J Rusnak","year":"2023","unstructured":"Rusnak J, Schupp T, Weidner K, Ruka M, Egner-Walter S, Forner J, Bertsch T, Kittel M, Mashayekhi K, Tajti P, Ayoub M, Akin I, Behnes M (2023) Outcome of patients with cardiogenic shock and previous right ventricular impairment represented by decreased tricuspid annular plane systolic excursion and tricuspid annular plane systolic excursion to pulmonary artery systolic pressure ratio. Am J Cardiol 207:431\u2013440","journal-title":"Am J Cardiol"},{"key":"10568_CR49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.acvd.2011.10.005","volume":"105","author":"R Gallet","year":"2012","unstructured":"Gallet R, Lellouche N, Mitchell-Heggs L, Bouhemad B, Bensaid A, Dubois-Rand\u00e9 J-L, Gueret P, Lim P (2012) Prognosis value of central venous oxygen saturation in acute decompensated heart failure. Arch Cardiovasc Dis 105:5\u201312","journal-title":"Arch Cardiovasc Dis"},{"key":"10568_CR50","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-025-05356-0","volume":"29","author":"B Levy","year":"2025","unstructured":"Levy B, Curtiaud A, Duarte K, Delmas C, Demiselle J, Girerd N, Gebhard CE, Helms J, Meziani F, Kimmoun A, Merdji H (2025) Association between mean hemodynamic variables during the first 24 h and outcomes in cardiogenic shock: identification of clinically relevant thresholds. Crit Care 29:137","journal-title":"Crit Care"},{"key":"10568_CR51","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","volume":"294","author":"C Binanay","year":"2005","unstructured":"Binanay C, Califf RM, Hasselblad V, O\u2019Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW, ESCAPE Investigators, ESCAPE Study Coordinators (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294:1625\u20131633","journal-title":"JAMA"},{"key":"10568_CR52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.hrtlng.2024.02.012","volume":"66","author":"B Wagaman","year":"2024","unstructured":"Wagaman B (2024) The efficacy of pulmonary artery catheters in reducing mortality in acute heart failure cardiogenic shock: a systematic review. Heart Lung 66:123\u2013128","journal-title":"Heart Lung"},{"key":"10568_CR53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.cardfail.2019.03.004","volume":"25","author":"A Hernandez Gabriel","year":"2019","unstructured":"Hernandez Gabriel A, Lemor A, Blumer V, Rueda CA, Zalawadiya S, Stevenson LW, Lindenfeld J (2019) Trends in utilization and outcomes of pulmonary artery catheterization in heart failure with and without cardiogenic shock. J Card Fail 25:364\u2013371","journal-title":"J Card Fail"},{"key":"10568_CR54","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cardfail.2023.05.001","volume":"29","author":"MK Kanwar","year":"2023","unstructured":"Kanwar MK, Blumer V, Zhang Y, Sinha SS, Garan AR, Hernandez-Montfort J, Khalif A, Hickey GW, Abraham J, Mahr C, Li B, Sangal P, Walec KD, Zazzali P, Kataria R, Pahuja M, Ton V-K, Harwani NM, Wencker D, Nathan S, Vorovich E, Hall S, Khalife W, Li S, Schwartzman A, Kim J, Vishnevsky OA, Trinquart L, Burkhoff D, Kapur NK (2023) Pulmonary artery catheter use and risk of in-hospital death in heart failure cardiogenic shock. J Card Fail 29:1234\u20131244","journal-title":"J Card Fail"},{"key":"10568_CR55","first-page":"903","volume":"8","author":"AR Garan","year":"2020","unstructured":"Garan AR, Kanwar M, Thayer KL, Whitehead E, Zweck E, Hernandez-Montfort J, Mahr C, Haywood JL, Harwani NM, Wencker D, Sinha SS, Vorovich E, Abraham J, O\u2019Neill W, Burkhoff D, Kapur NK (2020) Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality. JACC: Heart Failure 8:903\u2013913","journal-title":"JACC: Heart Failure"},{"key":"10568_CR56","first-page":"903","volume":"11","author":"BS Kadosh","year":"2023","unstructured":"Kadosh BS, Berg DD, Bohula EA, Park J-G, Baird-Zars VM, Alviar C, Alzate J, Barnett CF, Barsness GW, Burke J, Chaudhry S-P, Daniels LB, DeFilippis A, Delicce A, Fordyce CB, Ghafghazi S, Gidwani U, Goldfarb M, Katz JN, Keeley EC, Kenigsberg B, Kontos MC, Lawler PR, Leibner E, Menon V, Metkus TS, Miller PE, O\u2019Brien CG, Papolos AI, Prasad R, Shah KS, Sinha SS, Snell RJ, So D, Solomon MA, Ternus BW, Teuteberg JJ, Toole J, van Diepen S, Morrow DA, Roswell RO (2023) Pulmonary artery catheter use and mortality in the cardiac intensive care unit. JACC: Heart Failure 11:903\u2013914","journal-title":"JACC: Heart Failure"},{"key":"10568_CR57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000448110","volume":"136","author":"X Rossello","year":"2017","unstructured":"Rossello X, Vila M, Rivas-Lasarte M, Ferrero-Gregori A, Sans-Rosell\u00f3 J, Duran-Cambra A, Sionis A (2017) Impact of pulmonary artery catheter use on short- and long-term mortality in patients with cardiogenic shock. Cardiology 136:61\u201369","journal-title":"Cardiology"},{"key":"10568_CR58","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019843","volume":"10","author":"S Ranka","year":"2021","unstructured":"Ranka S, Mastoris I, Kapur NK, Tedford RJ, Rali A, Acharya P, Weidling R, Goyal A, Sauer AJ, Gupta B, Haglund N, Gupta K, Fang JC, Lindenfeld J, Shah Z (2021) Right heart catheterization in cardiogenic shock is associated with improved outcomes: insights from the nationwide readmissions database. J Am Heart Assoc 10:e019843","journal-title":"J Am Heart Assoc"},{"key":"10568_CR59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jointm.2022.10.002","volume":"3","author":"S Eftychiou","year":"2023","unstructured":"Eftychiou S, Kalakoutas A, Proudfoot A (2023) The role of temporary mechanical circulatory support in de novo heart failure syndromes with cardiogenic shock: a contemporary review. J Intensive Med 3:89\u2013103","journal-title":"J Intensive Med"},{"key":"10568_CR60","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCULATIONAHA.119.043080","volume":"141","author":"A Saxena","year":"2020","unstructured":"Saxena A, Garan AR, Kapur NK, O\u2019Neill WW, Lindenfeld J, Pinney SP, Uriel N, Burkhoff D, Kern M (2020) Value of hemodynamic monitoring in patients with cardiogenic shock undergoing mechanical circulatory support. Circulation 141:1184\u20131197","journal-title":"Circulation"},{"key":"10568_CR61","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation 145:e895\u2013e1032","journal-title":"Circulation"},{"key":"10568_CR62","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jacc.2024.04.069","volume":"84","author":"V-K Ton","year":"2024","unstructured":"Ton V-K, Li S, John K, Li B, Zweck E, Kanwar MK, Sinha SS, Hernandez-Montfort J, Garan AR, Goodman R, Faugno A, Farr M, Hall S, Kataria R, Guglin M, Vorovich E, Pahuja M, Vallabhajosyula S, Nathan S, Abraham J, Harwani NM, Hickey GW, Schwartzman AD, Khalife W, Mahr C, Kim JH, Bhimaraj A, Sangal P, Kong Q, Walec KD, Zazzali P, Fried J, Burkhoff D, Kapur NK (2024) Serial shock severity assessment within 72 hours after diagnosis. J Am Coll Cardiol 84:978\u2013990","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR63","first-page":"22","volume":"101","author":"N Morici","year":"2023","unstructured":"Morici N, Frea S, Bertaina M, Sacco A, Corrada E, Dini CS, Briani M, Tedeschi M, Saia F, Colombo C, Rota M, Oliva F, Iannaccone M, De Ferrari GM, Sionis A, Kapur NK, Tavazzi G, Pappalardo F (2023) SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: insights from the Altshock-2 registry. Catheter Cardiovasc Interv 101:22\u201332","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR64","first-page":"1625","volume":"12","author":"SM Patel","year":"2024","unstructured":"Patel SM, Berg DD, Bohula EA, Baird-Zars VM, Park J-G, Barnett CF, Daniels LB, Fordyce CB, Ghafghazi S, Goldfarb MJ, Gorder K, Kwon Y, Leibner E, Menon V, Potter BJ, Prasad R, Solomon MA, Teuteberg JJ, Thompson AD, Zakaria S, Katz JN, van Diepen S, Morrow DA (2024) Continuum of preshock to classic cardiogenic shock in the critical care cardiology trials network registry. JACC: Heart Failure 12:1625\u20131635","journal-title":"JACC: Heart Failure"},{"key":"10568_CR65","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ehjacc\/zuac087","volume":"11","author":"G Tavazzi","year":"2022","unstructured":"Tavazzi G, Rossello X, Grand J, Gierlotka M, Sionis A, Ahrens I, Hassager C, Price S (2022) Epidemiology, monitoring, and treatment strategy in cardiogenic shock. A multinational cross-sectional survey of ESC-acute cardiovascular care association research section. European Heart Journal. Acute Cardiovascular Care 11:706\u2013711","journal-title":"European Heart Journal. Acute Cardiovascular Care"},{"key":"10568_CR66","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cardfail.2021.08.012","volume":"27","author":"JA Marbach","year":"2021","unstructured":"Marbach JA, Stone S, Schwartz B, Pahuja M, Thayer KL, Faugno AJ, Chweich H, Rabinowitz JB, Kapur NK (2021) Lactate clearance is associated with improved survival in cardiogenic shock: a systematic review and meta-analysis of prognostic factor studies. J Card Fail 27:1082\u20131089","journal-title":"J Card Fail"},{"key":"10568_CR67","doi-asserted-by":"crossref","unstructured":"Basir MB, Lemor A, Gorgis S, Patel KC, Kolski BC, Bharadwaj AS, Todd JW, Tehrani BN, Truesdell AG, Lasorda DM, Lalonde TA, Kaki A, Schrieber TL, Patel NC, Senter SR, Gelormini JL, Marso SP, Rahman AM, Federici RE, Wilkins CE, Thomas McRae A, Nsair A, Caputo CP, Khuddus MA, Chahin JJ, Dupont AG, Goldsweig AM, Lim MJ, Kapur NK, Wohns DHW, Zhou Y, Hacala MJ, O\u2019Neill WW (2023) Early utilization of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the National Cardiogenic Shock Initiative. J Am Heart Assoc 12","DOI":"10.1161\/JAHA.123.031401"},{"key":"10568_CR68","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.amjcard.2017.06.049","volume":"120","author":"T J\u00e4ntti","year":"2017","unstructured":"J\u00e4ntti T, Tarvasm\u00e4ki T, Harjola V-P, Parissis J, Pulkki K, Sionis A, Silva-Cardoso J, K\u00f8ber L, Banaszewski M, Spinar J, Fuhrmann V, Tolonen J, Carubelli V, di Somma S, Mebazaa A, Lassus J, CardShock investigators (2017) Frequency and prognostic significance of abnormal liver function tests in patients with cardiogenic shock. Am J Cardiol 120:1090\u20131097","journal-title":"Am J Cardiol"},{"key":"10568_CR69","volume":"14","author":"M Jozwiak","year":"2024","unstructured":"Jozwiak M, Lim SY, Si X, Monnet X (2024) Biomarkers in cardiogenic shock: old pals, new friends. Ann Intensive Care 14:157","journal-title":"Ann Intensive Care"},{"key":"10568_CR70","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1002\/ehf2.14967","volume":"11","author":"C Li","year":"2024","unstructured":"Li C, Wang Y, Wang X, Shao C, Xin M, Xu B, Hao X, Jia M, Yang F, Wang L, Wang H, Hou X, Du Z (2024) Acute kidney injury and cardiogenic shock severity for mortality risk stratification in patients supported with VA ECMO. ESC Heart Fail 11:3872\u20133881","journal-title":"ESC Heart Fail"},{"key":"10568_CR71","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1002\/ehf2.14949","volume":"11","author":"C Leung","year":"2024","unstructured":"Leung C, Wong IMH, Ho CB, Chiang MCS, Fong YH, Lee PH, So TC, Yeung YK, Leung CY, Cheng YW, Chui SF, Chan AKC, Wong CY, Chan KT, Lee MKY (2024) Cardiac power output ratio: novel survival predictor after percutaneous ventricular assist device in cardiogenic shock. ESC Heart Fail 11:3674\u20133686","journal-title":"ESC Heart Fail"},{"key":"10568_CR72","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/ehf2.14853","volume":"11","author":"L Colarusso","year":"2024","unstructured":"Colarusso L, Brahmbhatt DH, Scolari FL, Keon KA, Shin E, Pellegrin Overgaard AID, Nisar M, Fung N, Ibrahimova N, Billia F, Overgaard CB, Luk AC (2024) Decoding cardiogenic shock: assessing shock index and its variants as prognostic indicators for in-hospital mortality. ESC Heart Fail 11:3023\u20133032","journal-title":"ESC Heart Fail"},{"key":"10568_CR73","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1002\/ehf2.15020","volume":"11","author":"M Chlabicz","year":"2024","unstructured":"Chlabicz M, \u0141aguna W, Kazimierczyk R, Kazimierczyk E, \u0141opatowska P, Gil M, Sobkowicz B, Kami\u0144ski KA, Tyci\u0144ska A (2024) Value of APACHE II, SOFA and CardShock scoring as predictive tools for cardiogenic shock: a single-centre pilot study. ESC Heart Fail 11:3584\u20133597","journal-title":"ESC Heart Fail"},{"key":"10568_CR74","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029232","author":"E Yamga","year":"2023","unstructured":"Yamga E, Mantena S, Rosen D, Bucholz EM, Yeh RW, Celi LA, Ustun B, Butala NM (2023) Optimized risk score to predict mortality in patients with cardiogenic shock in the cardiac intensive care unit. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.122.029232","journal-title":"J Am Heart Assoc"},{"key":"10568_CR75","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/eurheartj\/ehv194","volume":"36","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, Hodgson C, Scheinkestel C, Cooper DJ, Thiagarajan RR, Brodie D, Pellegrino V, Pilcher D (2015) Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J 36:2246\u20132256","journal-title":"Eur Heart J"},{"key":"10568_CR76","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00134-016-4223-9","volume":"42","author":"G Muller","year":"2016","unstructured":"Muller G, Flecher E, Lebreton G, Luyt C-E, Trouillet J-L, Br\u00e9chot N, Schmidt M, Mastroianni C, Chastre J, Leprince P, Anselmi A, Combes A (2016) The encourage mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med 42:370\u2013378","journal-title":"Intensive Care Med"},{"key":"10568_CR77","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ejhf.2449","volume":"24","author":"BN Beer","year":"2022","unstructured":"Beer BN, Jentzer JC, Weimann J, Dabboura S, Yan I, Sundermeyer J, Kirchhof P, Blankenberg S, Schrage B, Westermann D (2022) Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause - the cardiogenic shock score. Eur J Heart Fail 24:657\u2013667","journal-title":"Eur J Heart Fail"},{"key":"10568_CR78","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","volume":"17","author":"V-P Harjola","year":"2015","unstructured":"Harjola V-P, Lassus J, Sionis A, K\u00f8ber L, Tarvasm\u00e4ki T, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Di Somma S, Tolppanen H, Zeymer U, Thiele H, Nieminen MS, Mebazaa A, CardShock Study Investigators, GREAT network (2015) Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail 17:501\u2013509","journal-title":"Eur J Heart Fail"},{"key":"10568_CR79","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2017.02.027","volume":"69","author":"J P\u00f6ss","year":"2017","unstructured":"P\u00f6ss J, K\u00f6ster J, Fuernau G, Eitel I, de Waha S, Ouarrak T, Lassus J, Harjola V-P, Zeymer U, Thiele H, Desch S (2017) Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 69:1913\u20131920","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR80","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s11886-024-02108-4","volume":"26","author":"S Vallabhajosyula","year":"2024","unstructured":"Vallabhajosyula S, Sinha SS, Kochar A, Pahuja M, Amico FJ, Kapur NK (2024) The price we pay for progression in shock care: economic burden, accessibility, and adoption of shock-teams and mechanical circulatory support devices. Curr Cardiol Rep 26:1123\u20131134","journal-title":"Curr Cardiol Rep"},{"key":"10568_CR81","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cardfail.2024.06.020","volume":"30","author":"S Vallabhajosyula","year":"2024","unstructured":"Vallabhajosyula S, Ogunsakin A, Jentzer JC, Sinha SS, Kochar A, Gerberi DJ, Mullin CJ, Ahn SH, Sodha NR, Ventetuolo CE, Levine DJ, Abbott BG, Aliotta JM, Poppas A, Abbott JD (2024) Multidisciplinary care teams in acute cardiovascular care: a review of composition, logistics, outcomes, training, and future directions. J Card Fail 30:1367\u20131383","journal-title":"J Card Fail"},{"key":"10568_CR82","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cardfail.2024.01.007","volume":"30","author":"CL Alviar","year":"2024","unstructured":"Alviar CL, Hall S, Mebazaa A (2024) Outcomes of patients with cardiogenic shock in hub and spoke centers: the importance of protocol standardization at a network level. J Card Fail 30:576\u2013579","journal-title":"J Card Fail"},{"key":"10568_CR83","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0140-6736(24)01818-X","volume":"404","author":"E L\u00fcsebrink","year":"2024","unstructured":"L\u00fcsebrink E, Binzenh\u00f6fer L, Adamo M, Lorusso R, Mebazaa A, Morrow DA, Price S, Jentzer JC, Brodie D, Combes A, Thiele H (2024) Cardiogenic shock. Lancet 404:2006\u20132020","journal-title":"Lancet"},{"key":"10568_CR84","first-page":"768","volume":"10","author":"BN Tehrani","year":"2022","unstructured":"Tehrani BN, Sherwood MW, Rosner C, Truesdell AG, Lee SB, Damluji AA, Desai M, Desai S, Epps KC, Flanagan MC, Howard E, Ibrahim N, Kennedy J, Moukhachen H, Psotka M, Raja A, Saeed I, Shah P, Singh R, Sinha SS, Tang D, Welch T, Young K, deFilippi CR, Speir A, O\u2019Connor CM, Batchelor WB (2022) A standardized and regionalized network of care for cardiogenic shock. JACC: Heart Failure 10:768\u2013781","journal-title":"JACC: Heart Failure"},{"key":"10568_CR85","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","volume":"385","author":"R Mathew","year":"2021","unstructured":"Mathew R, Di SP, Jung RG, Marbach JA, Hutson J, Simard T, Ramirez FD, Harnett DT, Merdad A, Almufleh A, Weng W, Abdel-Razek O, Fernando SM, Kyeremanteng K, Bernick J, Wells GA, Chan V, Froeschl M, Labinaz M, Le MMR, Russo JJ, Hibbert B (2021) Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med 385:516\u2013525","journal-title":"N Engl J Med"},{"key":"10568_CR86","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ejhf.3162","volume":"26","author":"M Riccardi","year":"2024","unstructured":"Riccardi M, Pagnesi M, Chioncel O, Mebazaa A, Cotter G, Gustafsson F, Tomasoni D, Latronico N, Adamo M, Metra M (2024) Medical therapy of cardiogenic shock: contemporary use of inotropes and vasopressors. Eur J Heart Fail 26:411\u2013431","journal-title":"Eur J Heart Fail"},{"key":"10568_CR87","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00392-016-1009-6","volume":"105","author":"S Ishihara","year":"2016","unstructured":"Ishihara S, Gayat E, Sato N, Arrigo M, Laribi S, Legrand M, Placido R, Manivet P, Cohen-Solal A, Abraham WT, Jessup M, Mebazaa A (2016) Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure. Clin Res Cardiol 105:971\u2013980","journal-title":"Clin Res Cardiol"},{"key":"10568_CR88","doi-asserted-by":"crossref","unstructured":"Baldetti L, Pagnesi M, Gramegna M, Belletti A, Beneduce A, Pazzanese V, Calvo F, Sacchi S, Mieghem NM Van, Uil CA den, Metra M, Cappelletti AM (2021) Intra-aortic balloon pumping in acute decompensated heart failure with hypoperfusion: from pathophysiology to clinical practice. Circ Heart Fail 14","DOI":"10.1161\/CIRCHEARTFAILURE.121.008527"},{"key":"10568_CR89","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001076","volume":"146","author":"BJ Geller","year":"2022","unstructured":"Geller BJ, Sinha SS, Kapur NK, Bakitas M, Balsam LB, Chikwe J, Klein DG, Kochar A, Masri SC, Sims DB, Wong GC, Katz JN, van Diepen S, American Heart Association Acute Cardiac Care and General Cardiology Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary CCP and RC on CR and IC on C and SNC on PVD and C on CS and A (2022) Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association. Circulation 146:e50\u2013e68","journal-title":"Circulation"},{"key":"10568_CR90","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","volume":"52","author":"W Mullens","year":"2008","unstructured":"Mullens W, Abrahams Z, Francis GS, Skouri HN, Starling RC, Young JB, Taylor DO, Tang WHW (2008) Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 52:200\u2013207","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR91","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0002-8703(97)70030-9","volume":"134","author":"S Capomolla","year":"1997","unstructured":"Capomolla S, Pozzoli M, Opasich C, Febo O, Riccardi G, Salvucci F, Maestri R, Sisti M, Cobelli F, Tavazzi L (1997) Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. Am Heart J 134:1089\u20131098","journal-title":"Am Heart J"},{"key":"10568_CR92","doi-asserted-by":"crossref","unstructured":"Pagnesi M, Riccardi M, Sacco A, Tavecchia G, Viola G, Frea S, Briani M, Bertoldi LF, Bertaina M, Potena L, Valente S, Marini M, Ferrari GM De, D\u2019Ettore N, Cardinale A, Camporotondo R, Rota M, Tavazzi G, Morici N, Pappalardo F, Metra M, Altshock\u20102 investigators (2025) Pre-admission beta-blocker therapy and outcomes in cardiogenic shock: insights from the Altshock-2 Registry. ESC Heart Fail","DOI":"10.1002\/ehf2.15322"},{"key":"10568_CR93","volume":"48","author":"S Biswas","year":"2023","unstructured":"Biswas S, Malik AH, Bandyopadhyay D, Gupta R, Goel A, Briasoulis A, Fonarow GC, Lanier GM, Naidu SS (2023) Meta-analysis comparing the efficacy of dobutamine versus milrinone in acute decompensated heart failure and cardiogenic shock. Curr Probl Cardiol 48:101245","journal-title":"Curr Probl Cardiol"},{"issue":"6","key":"10568_CR94","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/0002-8703(91)90833-4","volume":"121","author":"RK Klocke","year":"1991","unstructured":"Klocke RK, Mager G, Kux A, H\u00f6pp H-W, Hilger HH (1991) Effects of a twenty-four-hour milrinone infusion in patients with severe heart failure and cardiogenic shock as a function of the hemodynamic initial condition. Am Heart J 121(6):1965\u20131973","journal-title":"Am Heart J"},{"key":"10568_CR95","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/ehf2.14379","volume":"10","author":"E Rodenas-Alesina","year":"2023","unstructured":"Rodenas-Alesina E, Luis Scolari F, Wang VN, Brahmbhatt DH, Mihajlovic V, Fung NL, Otsuki M, Billia F, Overgaard CB, Luk A (2023) Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure. ESC Heart Fail 10:2577\u20132587","journal-title":"ESC Heart Fail"},{"key":"10568_CR96","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"MS Cuffe","year":"2002","unstructured":"Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS, Massie BM, O\u2019Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M, Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators (2002) Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 287:1541\u20131547","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10568_CR97","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/0167-5273(90)90144-T","volume":"28","author":"JL Vincent","year":"1990","unstructured":"Vincent JL, L\u00e9on M, Berr\u00e9 J, M\u00e9lot C, Kahn RJ (1990) Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients. Int J Cardiol 28(Suppl 1):S7-11","journal-title":"Int J Cardiol"},{"key":"10568_CR98","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00003246-199208000-00006","volume":"20","author":"JL Vincent","year":"1992","unstructured":"Vincent JL, L\u00e9on M, Berr\u00e9 J, M\u00e9lot C, Kahn RJ (1992) Addition of enoximone to adrenergic agents in the management of severe heart failure. Crit Care Med 20:1102\u20131106","journal-title":"Crit Care Med"},{"key":"10568_CR99","doi-asserted-by":"crossref","unstructured":"Vincent JL, L\u00e9on M, Berr\u00e9 J (1990) The role of enoximone in the treatment of cardiogenic shock. Cardiology 77 Suppl 3:21\u201326; discussion 27\u201333.","DOI":"10.1159\/000174667"},{"key":"10568_CR100","volume":"11","author":"W-C Lee","year":"2022","unstructured":"Lee W-C, Wu P-J, Fang H-Y, Fang Y-N, Chen H-C, Tong M-S, Sung P-H, Lee C-H, Chung W-J (2022) Levosimendan administration may provide more benefit for survival in patients with non-ischemic cardiomyopathy experiencing acute decompensated heart failure. J Clin Med 11:3997","journal-title":"J Clin Med"},{"key":"10568_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113605","author":"W Juguet","year":"2020","unstructured":"Juguet W, Fard D, Faivre L, Koutsoukis A, Deguillard C, Mongardon N, Mekontso-Dessap A, Huguet R, Lim P (2020) Levosimendan plus dobutamine in acute decompensated heart failure refractory to dobutamine. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9113605","journal-title":"J Clin Med"},{"key":"10568_CR102","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.amjcard.2004.07.128","volume":"94","author":"JN Nanas","year":"2004","unstructured":"Nanas JN, Papazoglou PP, Terrovitis JV, Kanakakis J, Dalianis A, Tsolakis E, Tsagalou EP, Agrios N, Christodoulou K, Anastasiou-Nana MI (2004) Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone. Am J Cardiol 94:1329\u20131332","journal-title":"Am J Cardiol"},{"key":"10568_CR103","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/eurjhf\/hfn045","volume":"11","author":"A Mebazaa","year":"2009","unstructured":"Mebazaa A, Nieminen MS, Filippatos GS, Cleland JG, Salon JE, Thakkar R, Padley RJ, Huang B, Cohen-Solal A (2009) Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE. Eur J Heart Fail 11:304\u2013311","journal-title":"Eur J Heart Fail"},{"key":"10568_CR104","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2125.2003.02043.x","volume":"57","author":"S Antila","year":"2004","unstructured":"Antila S, Kivikko M, Lehtonen L, Eha J, Heikkil\u00e4 A, Pohjanjousi P, Pentik\u00e4inen PJ (2004) Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan. Br J Clin Pharmacol 57:412\u2013415","journal-title":"Br J Clin Pharmacol"},{"key":"10568_CR105","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/01.CIR.55.6.881","volume":"55","author":"RR Miller","year":"1977","unstructured":"Miller RR, Awan NA, Joye JA, Maxwell KS, DeMaria AN, Amsterdam EA, Mason DT (1977) Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction. Circulation 55:881\u2013884","journal-title":"Circulation"},{"key":"10568_CR106","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9149(78)90909-8","volume":"42","author":"DR Stemple","year":"1978","unstructured":"Stemple DR, Kleiman JH, Harrison DC (1978) Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions. Am J Cardiol 42:267\u2013275","journal-title":"Am J Cardiol"},{"key":"10568_CR107","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"Backer D De","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent J-L, SOAP II Investigators (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779\u2013789","journal-title":"N Engl J Med"},{"key":"10568_CR108","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/add6bc4f-dec0-4c95-a609-67563469b831","volume":"8","author":"R Pirracchio","year":"2013","unstructured":"Pirracchio R, Parenica J, Resche Rigon M, Chevret S, Spinar J, Jarkovsky J, Zannad F, Alla F, Mebazaa A (2013) The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis. PLoS ONE 8:e71659","journal-title":"PLoS ONE"},{"key":"10568_CR109","doi-asserted-by":"crossref","first-page":"A35","DOI":"10.1093\/eurheartj\/suab007","volume":"23","author":"LF Bertoldi","year":"2021","unstructured":"Bertoldi LF, Delmas C, Hunziker P, Pappalardo F (2021) Escalation and de-escalation of mechanical circulatory support in cardiogenic shock. Eur Heart J Suppl 23:A35\u2013A40","journal-title":"Eur Heart J Suppl"},{"key":"10568_CR110","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/ejhf.2629","volume":"24","author":"M Metra","year":"2022","unstructured":"Metra M, Chioncel O, Cotter G, Davison B, Filippatos G, Mebazaa A, Novosadova M, Ponikowski P, Simmons P, Soffer J, Simonson S (2022) Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock \u2013 a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC). Eur J Heart Fail 24:1967\u20131977","journal-title":"Eur J Heart Fail"},{"key":"10568_CR111","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.cardfail.2023.03.020","volume":"29","author":"M Metra","year":"2023","unstructured":"Metra M, Chioncel O, Davison B, Filippatos G, Mebazaa A, Pagnesi M, Adamo M, Novosadova M, Ponikowski P, Simmons P, Soffer J, Simonson S, Cotter G (2023) Safety and efficacy of istaroxime 1.0 and 1.5 \u00b5g\/kg\/min for patients with pre-cardiogenic shock. J Card Fail 29:1097\u20131103","journal-title":"J Card Fail"},{"key":"10568_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2025.05.013","author":"J Biegus","year":"2025","unstructured":"Biegus J, Mebazaa A, Metra M, Pagnesi M, Chioncel O, Davison B, Edwards C, Takagi K, Filippatos G, Tyci\u0144ska A, Novosadova M, Gulati G, Barros M, Diaz ML, Guardia C, Zymli\u0144ski R, Gajewski P, Ponikowski P, Simmons P, Simonson S, Cotter G (2025) Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shock. J Heart Lung Transplant. https:\/\/doi.org\/10.1016\/j.healun.2025.05.013","journal-title":"J Heart Lung Transplant"},{"key":"10568_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15102","author":"J Biegus","year":"2024","unstructured":"Biegus J, Mebazaa A, Metra M, Pagnesi M, Chioncel O, Davison B, Filippatos G, Tyci\u0144ska A, Novosadova M, Gulati G, Barros M, Diaz ML, Guardia C, Zymli\u0144ski R, Gajewski P, Ponikowski P, Simmons P, Simonson S, Cotter G (2024) Safety and efficacy of up to 60 h of IV istaroxime in pre-cardiogenic shock patients: design of the SEISMiC trial. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ehf2.15102","journal-title":"ESC Heart Fail"},{"key":"10568_CR114","first-page":"108","volume":"5","author":"DD Berg","year":"2016","unstructured":"Berg DD, Sukul D, O\u2019Brien M, Scirica BM, Sobieszczyk PS, Olenchock BA, Bohula EA, Morrow DA (2016) Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock. European Heart Journal: Acute Cardiovascular Care 5:108\u2013116","journal-title":"European Heart Journal: Acute Cardiovascular Care"},{"key":"10568_CR115","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1002\/ehf2.13546","volume":"8","author":"JM Haurand","year":"2021","unstructured":"Haurand JM, Haberkorn S, Haschemi J, Oehler D, Aubin H, Akhyari P, Boeken U, Kelm M, Westenfeld R, Horn P (2021) Outcome of patients with non-ischaemic cardiogenic shock supported by percutaneous left ventricular assist device. ESC Heart Fail 8:3594\u20133602","journal-title":"ESC Heart Fail"},{"key":"10568_CR116","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ejcts\/ezx088","volume":"52","author":"CA den Uil","year":"2017","unstructured":"den Uil CA, Akin S, Jewbali LS, dos Reis Miranda D, Brugts JJ, Constantinescu AA, Kappetein AP, Caliskan K (2017) Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg 52:14\u201325","journal-title":"Eur J Cardiothorac Surg"},{"key":"10568_CR117","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ejhf.2762","volume":"25","author":"AS Varshney","year":"2023","unstructured":"Varshney AS, Berg DD, Zhou G, Sinnenberg L, Hirji S, DeFilippis EM, Mallidi HR, Morrow DA, Rinewalt D, Givertz MM (2023) Bridging strategies and cardiac replacement outcomes in patients with acute decompensated heart failure-related cardiogenic shock. Eur J Heart Fail 25:425\u2013435","journal-title":"Eur J Heart Fail"},{"key":"10568_CR118","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101584","volume":"48","author":"K Barssoum","year":"2023","unstructured":"Barssoum K, Patel HP, Abdelmaseih R, Hassib M, Victor V, Mohamed A, Jazar DA, Mai S, Ibrahim F, Patel B, El Baeni A, Khalife W, Bandyopadhay D, Rai D, Chatila K (2023) Characteristics and outcomes of early vs late initiation of mechanical circulatory support in non-acute myocardial infarction related cardiogenic shock: an analysis of the National Inpatient Sample Database. Curr Probl Cardiol 48:101584","journal-title":"Curr Probl Cardiol"},{"key":"10568_CR119","volume":"2","author":"A Malik","year":"2023","unstructured":"Malik A, Basu T, VanAken G, Aggarwal V, Lee R, Abdul-Aziz A, Birati EY, Basir MB, Nallamothu BK, Shore S (2023) National trends for temporary mechanical circulatory support utilization in patients with cardiogenic shock from decompensated chronic heart failure: incidence, predictors, outcomes, and cost. J Soc Cardiovasc Angiogr Interv 2:101177","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10568_CR120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00392-017-1182-2","volume":"107","author":"M Shah","year":"2018","unstructured":"Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, Agrawal S, Arora S, Patel N, Wald J, Jorde UP (2018) Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 107:287\u2013303","journal-title":"Clin Res Cardiol"},{"key":"10568_CR121","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cardfail.2017.05.015","volume":"23","author":"SK Annamalai","year":"2017","unstructured":"Annamalai SK, Buiten L, Esposito ML, Paruchuri V, Mullin A, Breton C, Pedicini R, O\u2019Kelly R, Morine K, Wessler B, Patel AR, Kiernan MS, Karas RH, Kapur NK (2017) Acute hemodynamic effects of intra-aortic balloon counterpulsation pumps in advanced heart failure. J Card Fail 23:606\u2013614","journal-title":"J Card Fail"},{"key":"10568_CR122","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1510\/icvts.2006.140160","volume":"6","author":"I Norkiene","year":"2006","unstructured":"Norkiene I, Ringaitiene D, Rucinskas K, Samalavicius R, Baublys A, Miniauskas S, Sirvydis V (2006) Intra-aortic balloon counterpulsation in decompensated cardiomyopathy patients: bridge to transplantation or assist device. Interact Cardiovasc Thorac Surg 6:66\u201370","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10568_CR123","first-page":"583","volume":"24","author":"P Lauten","year":"2012","unstructured":"Lauten P, Rademacher W, Goebel B, Kretzschmar D, Figulla HR, Lauten A, Ferrari M (2012) Intra-aortic counterpulsation for hemodynamic support in patients with acute ischemic versus non-ischemic heart failure. J Invasive Cardiol 24:583\u2013588","journal-title":"J Invasive Cardiol"},{"key":"10568_CR124","doi-asserted-by":"crossref","unstructured":"Huang A, Fried J, Malick W, Topkara V, DeFilippis E, Haythe J, Farr M, Yuzefpolskaya M, Colombo P, Takeda K, Grandin E, Kirtane A, Pinto D, Garan A. Predictors of hemodynamic response to intra-aortic balloon pump therapy in patients with acute decompensated heart failure and cardiogenic shock. Journal of Invasive Cardiology 2021;33.","DOI":"10.25270\/jic\/20.00473"},{"key":"10568_CR125","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4244\/EIJ-D-19-00254","volume":"15","author":"CA den Uil","year":"2019","unstructured":"den Uil CA, Van MNM, Bastos MB, Jewbali LS, Lenzen MJ, Engstrom AE, Bunge JJH, Brugts JJ, Manintveld OC, Daemen J, Wilschut JM, Zijlstra F, Constantinescu AA (2019) Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial. EuroIntervention 15:586\u2013593","journal-title":"EuroIntervention"},{"key":"10568_CR126","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cardfail.2015.06.383","volume":"21","author":"MA Sintek","year":"2015","unstructured":"Sintek MA, Gdowski M, Lindman BR, Nassif M, Lavine KJ, Novak E, Bach RG, Silvestry SC, Mann DL, Joseph SM (2015) Intra-aortic balloon counterpulsation in patients with chronic heart failure and cardiogenic shock: clinical response and predictors of stabilization. J Card Fail 21:868\u2013876","journal-title":"J Card Fail"},{"key":"10568_CR127","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.amjcard.2019.09.016","volume":"124","author":"W Malick","year":"2019","unstructured":"Malick W, Fried JA, Masoumi A, Nair A, Zuver A, Huang A, Haythe J, Farr M, Rabbani L, Karmpaliotis D, Kirtane AJ, Topkara VK, Takeda K, Garan AR (2019) Comparison of the hemodynamic response to intra-aortic balloon counterpulsation in patients with cardiogenic shock resulting from acute myocardial infarction versus acute decompensated heart failure. Am J Cardiol 124:1947\u20131953","journal-title":"Am J Cardiol"},{"key":"10568_CR128","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ahj.2018.07.009","volume":"204","author":"N Morici","year":"2018","unstructured":"Morici N, Oliva F, Ajello S, Stucchi M, Sacco A, Cipriani MG, De BM, Garascia A, Gagliardone MP, Melisurgo G, Russo CF, La VC, Frigerio M, Pappalardo F (2018) Management of cardiogenic shock in acute decompensated chronic heart failure: the ALTSHOCK phase II clinical trial. Am Heart J 204:196\u2013201","journal-title":"Am Heart J"},{"key":"10568_CR129","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.healun.2018.03.011","volume":"37","author":"JA Fried","year":"2018","unstructured":"Fried JA, Nair A, Takeda K, Clerkin K, Topkara VK, Masoumi A, Yuzefpolskaya M, Takayama H, Naka Y, Burkhoff D, Kirtane A, Karmpaliotis D, Moses J, Colombo PC, Garan AR (2018) Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock. J Heart Lung Transplant 37:1313\u20131321","journal-title":"J Heart Lung Transplant"},{"key":"10568_CR130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000471846","volume":"138","author":"CA den Uil","year":"2017","unstructured":"den Uil CA, Galli G, Jewbali LS, Caliskan K, Manintveld OC, Brugts JJ, van Mieghem NM, Lenzen MJ, Boersma E, Constantinescu AA (2017) First-line support by intra-aortic balloon pump in non-ischaemic cardiogenic shock in the era of modern ventricular assist devices. Cardiology 138:1\u20138","journal-title":"Cardiology"},{"key":"10568_CR131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ahj.2017.11.016","volume":"199","author":"S Hsu","year":"2018","unstructured":"Hsu S, Thiruvengadam SK, Sciortino CM, Russell SD, Schulman SP (2018) Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock. Am Heart J 199:181\u2013191","journal-title":"Am Heart J"},{"key":"10568_CR132","first-page":"293","volume":"99","author":"JC Jentzer","year":"2022","unstructured":"Jentzer JC, van Diepen S, Henry TD, Baran DA, Barsness GW, Holmes DR (2022) Influence of intra-aortic balloon pump on mortality as a function of cardiogenic shock severity. Catheter Cardiovasc Interv 99:293\u2013304","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR133","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2025.03.003","volume":"85","author":"N Morici","year":"2025","unstructured":"Morici N, Sacco A, Frea S, Rota M, Villanova L, Gravinese C, Dini CS, D\u2019Ettore N, Maj G, De Lio G, Potena L, Valente S, Sabatino M, Viola G, Garatti L, Tavecchia GA, Bertoldi L, Oliva F, Kapur NK, Tavazzi G, De Ferrari GM, Pappalardo F, Altshock-2 Investigators (2025) Early intra-aortic balloon support for heart failure-related cardiogenic shock: a randomized clinical trial. J Am Coll Cardiol 85:1587\u20131597","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR134","doi-asserted-by":"crossref","DOI":"10.15420\/icr.2021.11","volume":"17","author":"R Zein","year":"2022","unstructured":"Zein R, Patel C, Mercado-Alamo A, Schreiber T, Kaki A (2022) A review of the Impella devices. Interv Cardiol 17:e05","journal-title":"Interv Cardiol"},{"key":"10568_CR135","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-1073-8","volume":"19","author":"P Gaudard","year":"2015","unstructured":"Gaudard P, Mourad M, Eliet J, Zeroual N, Culas G, Rouvi\u00e8re P, Albat B, Colson P (2015) Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Crit Care 19:363","journal-title":"Crit Care"},{"key":"10568_CR136","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.healun.2023.01.011","volume":"42","author":"D Ramzy","year":"2023","unstructured":"Ramzy D, Soltesz EG, Silvestry S, Daneshmand M, Kanwar M, D\u2019Alessandro DA (2023) Improved clinical outcomes associated with the Impella 5.5 compared to the Impella 5.0 in contemporary cardiogenic shock and heart failure patients. J Heart Lung Transplant 42:553\u2013557","journal-title":"J Heart Lung Transplant"},{"key":"10568_CR137","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/15569845211013329","volume":"16","author":"D Ramzy","year":"2021","unstructured":"Ramzy D, Anderson M, Batsides G, Ono M, Silvestry S, D\u2019Alessandro DA, Funamoto M, Zias EA, Lemaire A, Soltese E (2021) Early outcomes of the first 200 US patients treated with Impella 5.5: a novel temporary left ventricular assist device. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 16:365\u2013372","journal-title":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery"},{"key":"10568_CR138","doi-asserted-by":"crossref","DOI":"10.1016\/j.shj.2022.100072","volume":"6","author":"R Kataria","year":"2022","unstructured":"Kataria R, Khalil A, Coglianese E, Crowley J, Silverman MG, Shelton K, Michel E, D\u2019Alessandro D, Ton V-K (2022) Effect of Impella 5.5 on preexisting functional mitral regurgitation in patients with heart failure-related cardiogenic shock. Struct Heart 6:100072","journal-title":"Struct Heart"},{"key":"10568_CR139","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-018-1041-4","volume":"20","author":"MJ Chakaramakkil","year":"2018","unstructured":"Chakaramakkil MJ, Sivathasan C (2018) ECMO and short-term support for cardiogenic shock in heart failure. Curr Cardiol Rep 20:87","journal-title":"Curr Cardiol Rep"},{"key":"10568_CR140","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1002\/ehf2.13481","volume":"8","author":"S Seong","year":"2021","unstructured":"Seong S, Jin G, Kim M, Ahn KT, Yang JH, Gwon H, Ko Y, Yu CW, Chun WJ, Jang WJ, Kim H, Bae J, Kwon SU, Lee H, Lee WS, Park S, Cho SS, Ahn JH, Song PS, Jeong J (2021) Comparison of in-hospital outcomes of patients with vs. without ischaemic cardiomyopathy undergoing veno-arterial-extracorporeal membrane oxygenation. ESC Heart Fail 8:3308\u20133315","journal-title":"ESC Heart Fail"},{"key":"10568_CR141","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4244\/EIJV11I12A265","volume":"11","author":"S de Waha","year":"2016","unstructured":"de Waha S, Fuernau G, Desch S, Eitel I, Wiedau A, Lurz P, Schuler G, Thiele H (2016) Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort. EuroIntervention 11:1363\u20131371","journal-title":"EuroIntervention"},{"key":"10568_CR142","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ehf2.14584","volume":"11","author":"J Kang","year":"2024","unstructured":"Kang J, Lee K-S, Lee HS, Lee H, Ahn H, Han J-K, Yang H-M, Park KW, Lee H-Y, Kang H-J, Koo B-K, Kim H-S, Cho H-J (2024) Differential effect of left ventricular unloading according to the aetiology of cardiogenic shock. ESC Heart Fail 11:338\u2013348","journal-title":"ESC Heart Fail"},{"key":"10568_CR143","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2020.02.004","volume":"312","author":"L Baldetti","year":"2020","unstructured":"Baldetti L, Gramegna M, Beneduce A, Melillo F, Moroni F, Calvo F, Melisurgo G, Ajello S, Fominskiy E, Pappalardo F, Scandroglio AM (2020) Strategies of left ventricular unloading during VA-ECMO support: a network meta-analysis. Int J Cardiol 312:16\u201321","journal-title":"Int J Cardiol"},{"key":"10568_CR144","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00392-023-02208-1","volume":"113","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang L, Yao Y, Li Y, Qin W, Li Y, Xue W, Li P, Chen Y, Chen X, Guo H (2024) Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Clin Res Cardiol 113:509\u2013521","journal-title":"Clin Res Cardiol"},{"key":"10568_CR145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjcard.2023.09.023","volume":"208","author":"KD Gandhi","year":"2023","unstructured":"Gandhi KD, Moras EC, Niroula S, Lopez PD, Aggarwal D, Bhatia K, Balboul Y, Daibes J, Correa A, Dominguez AC, Birati EY, Baran DA, Serrao G, Mahmood K, Vallabhajosyula S, Fox A (2023) Left ventricular unloading with Impella versus IABP in patients with VA-ECMO: a systematic review and meta-analysis. Am J Cardiol 208:53\u201359","journal-title":"Am J Cardiol"},{"key":"10568_CR146","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ejhf.3178","volume":"26","author":"A Ughetto","year":"2024","unstructured":"Ughetto A, Aouinti S, Molinari N, Roubille F, Delmas C (2024) Early left ventricular unloading via active transseptal left atrial venting in case of cardiogenic shock under veno-arterial extracorporeal membrane oxygenation: a meta-analysis. Eur J Heart Fail 26:701\u2013703","journal-title":"Eur J Heart Fail"},{"key":"10568_CR147","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","volume":"147","author":"P Ostadal","year":"2023","unstructured":"Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, Naar J, Smalcova J, Hubatova M, Hromadka M, Volovar S, Seyfrydova M, Jarkovsky J, Svoboda M, Linhart A, Belohlavek J, ECMO-CS Investigators (2023) Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation 147:454\u2013464","journal-title":"Circulation"},{"key":"10568_CR148","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.healun.2015.08.018","volume":"34","author":"MB Anderson","year":"2015","unstructured":"Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, Kapur NK, Bansal A, Garcia J, Baker JN, Silvestry S, Holman WL, Douglas PS, O\u2019Neill W (2015) Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 34:1549\u20131560","journal-title":"J Heart Lung Transplant"},{"key":"10568_CR149","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.healun.2018.08.001","volume":"37","author":"M Anderson","year":"2018","unstructured":"Anderson M, Morris DL, Tang D, Batsides G, Kirtane A, Hanson I, Meraj P, Kapur NK, O\u2019Neill W (2018) Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device. J Heart Lung Transplant 37:1448\u20131458","journal-title":"J Heart Lung Transplant"},{"key":"10568_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12091481","author":"G Botti","year":"2022","unstructured":"Botti G, Gramegna M, Burzotta F, Masiero G, Briguori C, Trani C, Napodano M, Scandroglio AM, Montorfano M, Tarantini G, Chieffo A, IMP IT Investigators (2022) Impella RP for patients with acute right ventricular failure and cardiogenic shock: a subanalysis from the IMP-IT registry. J Pers Med. https:\/\/doi.org\/10.3390\/jpm12091481","journal-title":"J Pers Med"},{"key":"10568_CR151","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0140-6736(20)31047-3","volume":"396","author":"A Combes","year":"2020","unstructured":"Combes A, Price S, Slutsky AS, Brodie D (2020) Temporary circulatory support for cardiogenic shock. Lancet 396:199\u2013212","journal-title":"Lancet"},{"key":"10568_CR152","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10741-020-09971-7","volume":"27","author":"MP Weber","year":"2022","unstructured":"Weber MP, O\u2019Malley TJ, Choi JH, Maynes EJ, Prochno KW, Austin MA, Wood CT, Patel S, Morris RJ, Massey HT, Tchantchaleishvili V (2022) Outcomes of percutaneous temporary biventricular mechanical support: a systematic review. Heart Fail Rev 27:879\u2013890","journal-title":"Heart Fail Rev"},{"key":"10568_CR153","doi-asserted-by":"crossref","unstructured":"Kuchibhotla S, Esposito ML, Breton C, Pedicini R, Mullin A, O\u2019Kelly R, Anderson M, Morris DL, Batsides G, Ramzy D, Grise M, Pham DT, Kapur NK (2017) Acute biventricular mechanical circulatory support for cardiogenic shock. J Am Heart Assoc 6","DOI":"10.1161\/JAHA.117.006670"},{"key":"10568_CR154","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ehf2.12274","volume":"5","author":"F Pappalardo","year":"2018","unstructured":"Pappalardo F, Scandroglio AM, Latib A (2018) Full percutaneous biventricular support with two Impella pumps: the Bi-Pella approach. ESC Heart Fail 5:368\u2013371","journal-title":"ESC Heart Fail"},{"key":"10568_CR155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.hrtlng.2018.03.009","volume":"47","author":"C-Y Chiu","year":"2018","unstructured":"Chiu C-Y, H\u00e4ttasch R, Praeger D, Knebel F, Stangl K, Ramirez ID, Dreger H (2018) Percutaneous biventricular Impella support in therapy-refractory cardiogenic shock. Heart Lung 47:250\u2013252","journal-title":"Heart Lung"},{"key":"10568_CR156","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.hrtlng.2018.02.002","volume":"47","author":"GO Ogunbayo","year":"2018","unstructured":"Ogunbayo GO, Ha LD, Ahmad Q, Misumida N, Elbadawi A, Olorunfemi O, Kolodziej A, Messerli AW, Abdel-Latif A, Elayi CS, Guglin M (2018) In-hospital outcomes of percutaneous ventricular assist devices versus intra-aortic balloon pumps in non-ischemia related cardiogenic shock. Heart Lung 47:392\u2013397","journal-title":"Heart Lung"},{"key":"10568_CR157","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.034645","author":"A Watanabe","year":"2024","unstructured":"Watanabe A, Miyamoto Y, Ueyama H, Gotanda H, Tsugawa Y, Kuno T (2024) Percutaneous microaxial ventricular assist device versus intra-aortic balloon pump for nonacute myocardial infarction cardiogenic shock. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.123.034645","journal-title":"J Am Heart Assoc"},{"key":"10568_CR158","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s00392-020-01777-9","volume":"110","author":"K Karatolios","year":"2021","unstructured":"Karatolios K, Chatzis G, Markus B, Luesebrink U, Ahrens H, Divchev D, Syntila S, Jerrentrup A, Schieffer B (2021) Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis. Clin Res Cardiol 110:1404\u20131411","journal-title":"Clin Res Cardiol"},{"key":"10568_CR159","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ehjacc\/zuab121","volume":"11","author":"A Fagundes","year":"2022","unstructured":"Fagundes A, Berg DD, Bohula EA, Baird-Zars VM, Barnett CF, Carnicelli AP, Chaudhry S-P, Guo J, Keeley EC, Kenigsberg BB, Menon V, Miller PE, Newby LK, van Diepen S, Morrow DA, Katz JN (2022) End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) registry. European Heart Journal. Acute Cardiovascular Care 11:190\u2013197","journal-title":"European Heart Journal. Acute Cardiovascular Care"},{"key":"10568_CR160","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.011954","author":"S Vallabhajosyula","year":"2019","unstructured":"Vallabhajosyula S, Prasad A, Dunlay SM, Murphree DH, Ingram C, Mueller PS, Gersh BJ, Holmes DR, Barsness GW (2019) Utilization of palliative care for cardiogenic shock complicating acute myocardial infarction: a 15-year national perspective on trends, disparities, predictors, and outcomes. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.119.011954","journal-title":"J Am Heart Assoc"},{"key":"10568_CR161","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4037\/ajcc2024535","volume":"33","author":"A Sacco","year":"2024","unstructured":"Sacco A, Pagnesi M, Frea S, Briani M, Dini CS, Bertaina M, Marini M, Trombara F, Villanova L, Ravera A, Tavazzi G, Pappalardo F, Morici N, Potena L (2024) Transitioning to palliative care in an Italian cardiac intensive care unit network. Am J Crit Care 33:145\u2013148","journal-title":"Am J Crit Care"},{"key":"10568_CR162","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cardfail.2021.01.020","volume":"27","author":"Z Feng","year":"2021","unstructured":"Feng Z, Fonarow GC, Ziaeian B (2021) Palliative care services in patients admitted with cardiogenic shock in the United States: frequency and predictors of 30-day readmission. J Card Fail 27:560\u2013567","journal-title":"J Card Fail"},{"key":"10568_CR163","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/jpm.2018.0393","volume":"22","author":"S Nakagawa","year":"2019","unstructured":"Nakagawa S, Garan AR, Takeda K, Takayama H, Topkara VK, Yuzefpolskaya M, Yuill L, Lin SX, Colombo PC, Naka Y, Blinderman CD (2019) Palliative care consultation in cardiogenic shock requiring short-term mechanical circulatory support: a retrospective cohort study. J Palliat Med 22:432\u2013436","journal-title":"J Palliat Med"},{"key":"10568_CR164","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","volume":"27","author":"MS Nieminen","year":"2006","unstructured":"Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola V-P, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L (2006) Euroheart failure survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725\u20132736","journal-title":"Eur Heart J"},{"key":"10568_CR165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ahj.2011.03.033","volume":"162","author":"O Chioncel","year":"2011","unstructured":"Chioncel O, Vinereanu D, Datcu M, Ionescu DD, Capalneanu R, Brukner I, Dorobantu M, Ambrosy A, Macarie C, Gheorghiade M (2011) The Romanian acute heart failure syndromes (RO-AHFS) registry. Am Heart J 162:142-153.e1","journal-title":"Am Heart J"},{"key":"10568_CR166","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/eurjhf\/hfs117","volume":"14","author":"F Oliva","year":"2012","unstructured":"Oliva F, Mortara A, Cacciatore G, Chinaglia A, Lenarda AD, Gorini M, Metra M, Senni M, Maggioni AP, Tavazzi L (2012) Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian registry on heart failure outcome. Eur J Heart Fail 14:1208\u20131217","journal-title":"Eur J Heart Fail"},{"key":"10568_CR167","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/eurjhf\/hfs189","volume":"15","author":"D Logeart","year":"2013","unstructured":"Logeart D, Isnard R, Resche-Rigon M, Seronde M, de Groote P, Jondeau G, Galinier M, Mulak G, Donal E, Delahaye F, Juilliere Y, Damy T, Jourdain P, Bauer F, Eicher J, Neuder Y, Trochu J (2013) Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail 15:465\u2013476","journal-title":"Eur J Heart Fail"},{"key":"10568_CR168","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ejhf.566","volume":"18","author":"MG Crespo-Leiro","year":"2016","unstructured":"Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, Ferrari R, Piepoli MF, Delgado Jimenez JF, Metra M, Fonseca C, Hradec J, Amir O, Logeart D, Dahlstr\u00f6m U, Merkely B, Drozdz J, Goncalvesova E, Hassanein M, Chioncel O, Lainscak M, Seferovic PM, Tousoulis D, Kavoliuniene A, Fruhwald F, Fazlibegovic E, Temizhan A, Gatzov P, Erglis A, Laroche C, Mebazaa A (2016) European society of cardiology heart failure long-term registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail 18:613\u2013625","journal-title":"Eur J Heart Fail"},{"key":"10568_CR169","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ejhf.1492","volume":"21","author":"O Chioncel","year":"2019","unstructured":"Chioncel O, Mebazaa A, Maggioni AP, Harjola V, Rosano G, Laroche C, Piepoli MF, Crespo-Leiro MG, Lainscak M, Ponikowski P, Filippatos G, Ruschitzka F, Seferovic P, Coats AJS, Lund LH (2019) Acute heart failure congestion and perfusion status \u2013 impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA heart failure long-term registry. Eur J Heart Fail 21:1338\u20131352","journal-title":"Eur J Heart Fail"},{"key":"10568_CR170","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/ejhf.1502","volume":"21","author":"P Javaloyes","year":"2019","unstructured":"Javaloyes P, Mir\u00f3 \u00d2, Gil V, Mart\u00edn-S\u00e1nchez FJ, Jacob J, Herrero P, Takagi K, Alqu\u00e9zar-Arb\u00e9 A, L\u00f3pez D\u00edez MP, Mart\u00edn E, Bibiano C, Escoda R, Gil C, Fuentes M, Llopis Garc\u00eda G, \u00c1lvarez P\u00e9rez JM, Jerez A, Tost J, Llauger L, Romero R, Garrido JM, Rodr\u00edguez-Adrada E, S\u00e1nchez C, Rossello X, Parissis J, Mebazaa A, Chioncel O, Llorens P (2019) Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes. Eur J Heart Fail 21:1353\u20131365","journal-title":"Eur J Heart Fail"},{"key":"10568_CR171","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/ejhf.2918","volume":"25","author":"O Chioncel","year":"2023","unstructured":"Chioncel O, Adamo M, Nikolaou M, Parissis J, Mebazaa A, Yilmaz MB, Hassager C, Moura B, Bauersachs J, Harjola V, Antohi E, Ben-Gal T, Collins SP, Iliescu VA, Abdelhamid M, \u010celutkien\u0117 J, Adamopoulos S, Lund LH, Cicoira M, Masip J, Skouri H, Gustafsson F, Rakisheva A, Ahrens I, Mortara A, Janowska EA, Almaghraby A, Damman K, Miro O, Huber K, Ristic A, Hill L, Mullens W, Chieffo A, Bartunek J, Paolisso P, Bayes-Genis A, Anker SD, Price S, Filippatos G, Ruschitzka F, Seferovic P, Vidal-Perez R, Vahanian A, Metra M, McDonagh TA, Barbato E, Coats AJS, Rosano GMC (2023) Acute heart failure and valvular heart disease: a scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. Eur J Heart Fail 25:1025\u20131048","journal-title":"Eur J Heart Fail"},{"key":"10568_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3549","author":"E L\u00fcsebrink","year":"2024","unstructured":"L\u00fcsebrink E, Lanz H, Kellnar A, Karam N, Kapadia S, Makkar R, Abraham WT, Latib A, Leon M, Sannino A, Shuvy M, Guerrero M, Fam N, Butler J, Adamo M, Rudolph V, Tang GHL, Stocker TJ, Rommel K, Lurz P, Thiele H, Massberg S, Praz F, Prendergast B, Hausleiter J (2024) Management of acute decompensated valvular heart disease. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.3549","journal-title":"Eur J Heart Fail"},{"key":"10568_CR173","doi-asserted-by":"crossref","unstructured":"Carnicelli AP, Miller PE, Berg DD, Aliyev N, Alviar CL, Bohula EA, Chaudhry S-P, Chonde M, Chow C, Cooper HA, Daniels LB, Fordyce CB, Ghafghazi S, Goldfarb MJ, Gorder KL, Hamilton MM, Keane RR, Kontos MC, Kusner JJ, Leibner E, Loriaux DB, Menon V, Nair RM, Newby LK, Oduah M-T, Palazzolo MG, Patolia H, Pierce JB, Pierce MJ, Potter BJ, Proudfoot A, Roswel RO, Schnell G, Shaw J, Sidhu K, Sinha SS, Varshney AS, Katz JN, Diepen S Van, Morrow DA (2025) Characteristics and outcomes of patients with cardiogenic shock and clinically significant valvular heart disease: from the critical care cardiology trials network. J Card Fail","DOI":"10.1016\/j.cardfail.2025.01.019"},{"key":"10568_CR174","doi-asserted-by":"crossref","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, Jneid H, Krieger E V., Mack M, McLeod C, O\u2019Gara PT, Rigolin VH, Sundt TM, Thompson A, Toly C (2021) 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 143","DOI":"10.1161\/CIR.0000000000000923"},{"key":"10568_CR175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, Bonis MD, Paulis RD, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, J\u00fcni P, Pierard L, Prendergast BD, S\u00e1daba JR, Tribouilloy C, Wojakowski W, Neumann F-J, Myers P, Abdelhamid M, Achenbach S, Asteggiano R, Barili F, Borger MA, Carrel T, Collet J-P, Foldager D, Habib G, Hassager C, Irs A, Iung B, Jahangiri M, Katus HA, Koskinas KC, Massberg S, Mueller CE, Nielsen JC, Pibarot P, Rakisheva A, Roffi M, Rubboli A, Shlyakhto E, Siepe M, Sitges M, Sondergaard L, Sousa-Uva M, Tarantini G, Zamorano JL, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, Bonis MD, Paulis RD, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, J\u00fcni P, Pierard L, Prendergast BD, S\u00e1daba JR, Tribouilloy C, Wojakowski W, Benchabi Y, Chilingaryan A, Metzler B, Rustamova Y, Shumavets V, Lancellotti P, Smajic E, Trendafilova-Lazarova D, Samardzic J, Karakyriou M, Palecek T, Sanchez Dahl J, Meshaal MS, Palm K, Virtanen M, Bouleti C, Bakhutashvili Z, Achenbach S, Boutsikou M, Kert\u00e9sz AB, Danielsen R, Topilsky Y, Golino P, Tuleutayev R, Elezi S, Kerimkulov A, Rudzitis A, Glaveckaite S, Sow R, Demarco DC, Bulatovic N, Aouad A, Brink R, Antova E, Beitnes JO, Ochala A, Ribeiras R, Vinereanu D, Irtyuga O, Ivanovic B, Simkova I, Gonz\u00e1lez G\u00f3mez A, Sarno G, Pedrazzini GB, Bsata W, Zakhama L, Korkmaz L, Cherniuk S, Khanji MY, Sharipov I (2022) 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43:561\u2013632","journal-title":"Eur Heart J"},{"key":"10568_CR176","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009653","volume":"16","author":"K Sivaraj","year":"2023","unstructured":"Sivaraj K, Arora S, Hendrickson M, Slehria T, Chang PP, Weickert T, Vaduganathan M, Qamar A, Pandey A, Caughey MC, Cavender MA, Rosamond W, Vavalle JP (2023) Epidemiology and outcomes of aortic stenosis in acute decompensated heart failure: the ARIC study. Circ Heart Fail 16:e009653","journal-title":"Circ Heart Fail"},{"key":"10568_CR177","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1253\/circj.CJ-17-0610","volume":"82","author":"K Nagao","year":"2018","unstructured":"Nagao K, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T, CURRENT AS Registry Investigators (2018) Acute heart failure in patients with severe aortic stenosis - insights from the CURRENT AS registry. Circ J 82:874\u2013885","journal-title":"Circ J"},{"key":"10568_CR178","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/eurheartj\/ehad387","volume":"44","author":"K Goel","year":"2023","unstructured":"Goel K, Shah P, Jones BM, Korngold E, Bhardwaj A, Kar B, Barker C, Szerlip M, Smalling R, Dhoble A (2023) Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock. Eur Heart J 44:3181\u20133195","journal-title":"Eur Heart J"},{"key":"10568_CR179","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcin.2020.02.033","volume":"13","author":"L Masha","year":"2020","unstructured":"Masha L, Vemulapalli S, Manandhar P, Balan P, Shah P, Kosinski AS, Stewart G (2020) Demographics, procedural characteristics, and clinical outcomes when cardiogenic shock precedes TAVR in the United States. JACC Cardiovasc Interv 13:1314\u20131325","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR180","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/0885066620918776","volume":"36","author":"JC Jentzer","year":"2021","unstructured":"Jentzer JC, Ternus B, Eleid M, Rihal C (2021) Structural heart disease emergencies. J Intensive Care Med 36:975\u2013988","journal-title":"J Intensive Care Med"},{"key":"10568_CR181","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.annemergmed.2015.03.027","volume":"66","author":"D Claveau","year":"2015","unstructured":"Claveau D, Piha-Gossack A, Friedland SN, Afilalo J, Rudski L (2015) Complications associated with nitrate use in patients presenting with acute pulmonary edema and concomitant moderate or severe aortic stenosis. Ann Emerg Med 66:355-362.e1","journal-title":"Ann Emerg Med"},{"issue":"10","key":"10568_CR182","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/BF03018495","volume":"51","author":"NM Skjodt","year":"2004","unstructured":"Skjodt NM, Townsend DR (2004) Best evidence in critical care medicine: treatment: vasodilatation with nitroprusside in symptomatic patients with severe aortic stenosis and congestive heart failure improves cardiac index. Can J Anaesth 51(10):1042\u20131044","journal-title":"Can J Anaesth"},{"key":"10568_CR183","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa022021","volume":"348","author":"UN Khot","year":"2003","unstructured":"Khot UN, Novaro GM, Popovi\u0107 ZB, Mills RM, Thomas JD, Tuzcu EM, Hammer D, Nissen SE, Francis GS (2003) Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 348:1756\u20131763","journal-title":"N Engl J Med"},{"key":"10568_CR184","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/1755-5922.12132","volume":"33","author":"MJ Garc\u00eda-Gonz\u00e1lez","year":"2015","unstructured":"Garc\u00eda-Gonz\u00e1lez MJ, Jorge-P\u00e9rez P, Jim\u00e9nez-Sosa A, Acea AB, Lacalzada Almeida JB, Ferrer Hita JJ (2015) Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study. Cardiovasc Ther 33:193\u2013199","journal-title":"Cardiovasc Ther"},{"key":"10568_CR185","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2018.06.074","volume":"72","author":"CL Alviar","year":"2018","unstructured":"Alviar CL, Miller PE, McAreavey D, Katz JN, Lee B, Moriyama B, Soble J, van Diepen S, Solomon MA, Morrow DA, ACC Critical Care Cardiology Working Group (2018) Positive pressure ventilation in the cardiac intensive care unit. J Am Coll Cardiol 72:1532\u20131553","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR186","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/joic.12323","volume":"29","author":"V Singh","year":"2016","unstructured":"Singh V, Damluji AA, Mendirichaga R, Alfonso CE, Martinez CA, Williams D, Heldman AW, de Marchena EJ, O\u2019Neill WW, Cohen MG (2016) Elective or emergency use of mechanical circulatory support devices during transcatheter aortic valve replacement. J Interv Cardiol 29:513\u2013522","journal-title":"J Interv Cardiol"},{"key":"10568_CR187","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00380-018-1183-8","volume":"33","author":"R Higuchi","year":"2018","unstructured":"Higuchi R, Tobaru T, Hagiya K, Saji M, Takamisawa I, Shimizu J, Iguchi N, Takanashi S, Takayama M, Isobe M (2018) Outcomes of patients requiring extracorporeal membrane oxygenation in transcatheter aortic valve implantation: a clinical case series. Heart Vessels 33:1343\u20131349","journal-title":"Heart Vessels"},{"key":"10568_CR188","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11748-017-0757-1","volume":"65","author":"K Uehara","year":"2017","unstructured":"Uehara K, Minakata K, Saito N, Imai M, Daijo H, Nakatsu T, Sakamoto K, Yamazaki K, Kimura T, Sakata R (2017) Use of extracorporeal membrane oxygenation in complicated transcatheter aortic valve replacement. Gen Thorac Cardiovasc Surg 65:329\u2013336","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10568_CR189","volume":"7","author":"T Osawa","year":"2023","unstructured":"Osawa T, Watabe H, Hoshi T, Ieda M (2023) Emergency transcatheter aortic valve implantation with a self-expandable valve under extracorporeal membrane oxygenation for cardiogenic shock due to bicuspid aortic stenosis: a case report. Eur Heart J 7:ytad304","journal-title":"Eur Heart J"},{"key":"10568_CR190","volume":"5","author":"M Ahsan","year":"2021","unstructured":"Ahsan M, J\u00e1nosi RA, Rassaf T, Lind A (2021) Use of extracorporeal membrane oxygenation as a bridge to transcatheter aortic valve replacement in a patient with aortic stenosis and severe coronary artery disease: a case report. Eur Heart J 5:ytaa567","journal-title":"Eur Heart J"},{"key":"10568_CR191","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7598581","volume":"2019","author":"H Huang","year":"2019","unstructured":"Huang H, Kovach CP, Bell S, Reisman M, Aldea G, McCabe JM, Dvir D, Don C (2019) Outcomes of emergency transcatheter aortic valve replacement. J Interv Cardiol 2019:7598581","journal-title":"J Interv Cardiol"},{"key":"10568_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58030356","author":"Y-L Niu","year":"2022","unstructured":"Niu Y-L, Mayr NP, Chen Y-H, Chang H-H, Wang S-P, Lin H-Y, Pai C-C (2022) Successful urgent TAVI for critical aortic valve stenosis after ECMO implantation. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina58030356","journal-title":"Medicina (Kaunas)"},{"key":"10568_CR193","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/hrt.2010.206367","volume":"97","author":"O Aksoy","year":"2011","unstructured":"Aksoy O, Yousefzai R, Singh D, Agarwal S, O\u2019Brien B, Griffin BP, Kapadia SR, Tuzcu ME, Penn MS, Nissen SE, Menon V (2011) Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump support. Heart 97:838\u2013843","journal-title":"Heart"},{"key":"10568_CR194","volume":"20","author":"V Singh","year":"2018","unstructured":"Singh V, Mendirichaga R, Inglessis-Azuaje I, Palacios IF, O\u2019Neill WW (2018) The role of Impella for hemodynamic support in patients with aortic stenosis. Curr Treat Options Cardiovasc Med 20:44","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10568_CR195","first-page":"485","volume":"26","author":"DW Johnson","year":"2017","unstructured":"Johnson DW, Erwin IIIJP (2017) Use of Impella 5.0 prior to transcatheter aortic valve replacement in a patient with severe aortic stenosis and cardiogenic shock. J Heart Valve Dis 26:485\u2013487","journal-title":"J Heart Valve Dis"},{"key":"10568_CR196","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.amjcard.2019.08.013","volume":"124","author":"A Alkhalil","year":"2019","unstructured":"Alkhalil A, Hajjar R, Ibrahim H, Ruiz CE (2019) Mechanical circulatory support in transcatheter aortic valve implantation in the United States (from the National Inpatient Sample). Am J Cardiol 124:1615\u20131620","journal-title":"Am J Cardiol"},{"key":"10568_CR197","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.jvca.2019.09.025","volume":"34","author":"Y-H Ching","year":"2020","unstructured":"Ching Y-H, Qu G, Arnaoutakis GJ, Wayangankar S, Peng YG (2020) Use of Impella support in transcatheter aortic valve replacement for a patient with severe aortic stenosis and significantly reduced ejection fraction. J Cardiothorac Vasc Anesth 34:744\u2013746","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10568_CR198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2023.03.006","volume":"53","author":"MR Almajed","year":"2023","unstructured":"Almajed MR, Mahmood S, Obri M, Nona P, Gonzalez PE, Chiang M, Wang DD, Frisoli T, Lee J, Basir M, O\u2019Neill B, O\u2019Neill W, Villablanca P (2023) Application of Impella mechanical circulatory support devices in transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single-center experience. Cardiovasc Revasc Med 53:1\u20137","journal-title":"Cardiovasc Revasc Med"},{"key":"10568_CR199","first-page":"357","volume":"95","author":"M Almalla","year":"2020","unstructured":"Almalla M, Kersten A, Altiok E, Marx N, Schr\u00f6der JW (2020) Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: a single center experience. Catheter Cardiovasc Interv 95:357\u2013362","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR200","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/ehjacc\/zuac131","volume":"11","author":"J Steffen","year":"2022","unstructured":"Steffen J, Stocker A, Scherer C, Haum M, Fischer J, Doldi PM, Theiss H, Braun D, Rizas K, Peter\u00df S, Hausleiter J, Massberg S, Orban M, Deseive S (2022) Emergency transcatheter aortic valve implantation for acute heart failure due to severe aortic stenosis in critically ill patients with or without cardiogenic shock. European Heart Journal. Acute Cardiovascular Care 11:877\u2013886","journal-title":"European Heart Journal. Acute Cardiovascular Care"},{"key":"10568_CR201","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.4244\/EIJY15M03_03","volume":"11","author":"C Frerker","year":"2016","unstructured":"Frerker C, Schewel J, Schl\u00fcter M, Schewel D, Ramadan H, Schmidt T, Thielsen T, Kreidel F, Schlingloff F, Bader R, Wohlmuth P, Sch\u00e4fer U, Kuck K-H (2016) Emergency transcatheter aortic valve replacement in patients with cardiogenic shock due to acutely decompensated aortic stenosis. EuroIntervention 11:1530\u20131536","journal-title":"EuroIntervention"},{"key":"10568_CR202","first-page":"2117","volume":"99","author":"P-G Piriou","year":"2022","unstructured":"Piriou P-G, Manigold T, Letocart V, Le RR, Schurtz G, Vincent F, Van B\u00c9, Gu\u00e9rin P, Plessis J (2022) Outcomes of emergency transcatheter aortic valve replacement in patients with cardiogenic shock: a multicenter retrospective study. Catheter Cardiovasc Interv 99:2117\u20132124","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR203","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2024-003110","author":"SG K\u00fchne","year":"2025","unstructured":"K\u00fchne SG, Patrignani A, Elvinger S, Wein B, Harmel E, Penev D, Owais T, Girdauskas E, Raake PW, Chiarito M, Bongiovanni D (2025) Emergency interventions for cardiogenic shock due to decompensated aortic stenosis: a systematic review and meta-analysis. Open Heart. https:\/\/doi.org\/10.1136\/openhrt-2024-003110","journal-title":"Open Heart"},{"key":"10568_CR204","first-page":"1128","volume":"96","author":"C Fraccaro","year":"2020","unstructured":"Fraccaro C, Campante Teles R, Tch\u00e9tch\u00e9 D, Saia F, Bedogni F, Montorfano M, Fiorina C, Meucci F, De Benedictis M, Leonzi O, Barbierato M, Dumonteil N, Stolcova M, Maffeo D, Compagnone M, Brito J, Chieffo A, Tarantini G (2020) Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results. Catheter Cardiovasc Interv 96:1128\u20131135","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR205","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jcin.2018.03.002","volume":"11","author":"D Kolte","year":"2018","unstructured":"Kolte D, Khera S, Vemulapalli S, Dai D, Heo S, Goldsweig AM, Aronow HD, Elmariah S, Inglessis I, Palacios IF, Thourani VH, Sharaf BL, Gordon PC, Abbott JD (2018) Outcomes following urgent\/emergent transcatheter aortic valve replacement. JACC Cardiovasc Interv 11:1175\u20131185","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR206","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.hrtlng.2024.09.011","volume":"69","author":"Y Deng","year":"2025","unstructured":"Deng Y, Wei S, Zhu L, Tao L (2025) Effectiveness and safety of emergency transcatheter aortic valve replacement in patients with severe aortic stenosis complicated by cardiogenic shock: a systematic review and meta-analysis. Heart Lung 69:62\u201370","journal-title":"Heart Lung"},{"key":"10568_CR207","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001467","volume":"7","author":"Y Enta","year":"2020","unstructured":"Enta Y, Miyasaka M, Taguri M, Tada N, Hata M, Watanabe Y, Naganuma T, Yamawaki M, Yamanaka F, Shirai S, Ueno H, Mizutani K, Tabata M, Takagi K, Yamamoto M, Hayashida K (2020) Patients\u2019 characteristics and mortality in urgent\/emergent\/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry. Open Heart 7:e001467","journal-title":"Open Heart"},{"key":"10568_CR208","first-page":"726","volume":"32","author":"U Landes","year":"2016","unstructured":"Landes U, Orvin K, Codner P, Assali A, Vaknin-Assa H, Schwartznberg S, Levi A, Shapira Y, Sagie A, Kornowski R (2016) Urgent transcatheter aortic valve implantation in patients with severe aortic stenosis and acute heart failure: procedural and 30-day outcomes. Can J Cardiol 32:726\u2013731","journal-title":"Can J Cardiol"},{"key":"10568_CR209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/7230063","volume":"2021","author":"R Shao","year":"2021","unstructured":"Shao R, Li J, Qu T, Fu X, Liao Y, Chen M (2021) Efficacy and safety of emergent transcatheter aortic valve implantation in patients with acute decompensated aortic stenosis: systematic review and meta-analysis. J Interv Cardiol 2021:1\u201315","journal-title":"J Interv Cardiol"},{"key":"10568_CR210","first-page":"1110","volume":"100","author":"A Elkaryoni","year":"2022","unstructured":"Elkaryoni A, Cohen DJ, Lopez JJ, Huded CP, Kennedy KF, Arnold SV (2022) Trends in invasive treatment of patients hospitalized with aortic stenosis complicated by cardiogenic shock. Catheter Cardiovasc Interv 100:1110\u20131116","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR211","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-18-00029","volume":"14","author":"N Debry","year":"2018","unstructured":"Debry N, Kone P, Vincent F, Lemesle G, Delhaye C, Schurtz G, Spillemaeker H, Porouchani S, Coisne A, Auffray J-L, Sudre A, Lamblin N, Bonello L, Belle EV (2018) Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters. EuroIntervention 14:e519\u2013e525","journal-title":"EuroIntervention"},{"key":"10568_CR212","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/heartjnl-2019-315904","volume":"106","author":"T Williams","year":"2020","unstructured":"Williams T, Hildick-Smith DJR (2020) Balloon aortic valvuloplasty: indications, patient eligibility, technique and contemporary outcomes. Heart 106:1102\u20131110","journal-title":"Heart"},{"key":"10568_CR213","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11739-013-0972-4","volume":"9","author":"HD Theiss","year":"2014","unstructured":"Theiss HD, Greif M, Steinbeck G, Kupatt C, Franz WM (2014) Balloon valvuloplasty for treatment of cardiogenic shock in the era of surgical valve replacement and TAVI. Intern Emerg Med 9:345\u2013347","journal-title":"Intern Emerg Med"},{"key":"10568_CR214","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.hjc.2018.02.008","volume":"60","author":"K Karatolios","year":"2019","unstructured":"Karatolios K, Chatzis G, Luesebrink U, Markus B, Ahrens H, Tousoulis D, Schieffer B (2019) Impella support following emergency percutaneous balloon aortic valvuloplasty in patients with severe aortic valve stenosis and cardiogenic shock. Hellenic J Cardiol 60:178\u2013181","journal-title":"Hellenic J Cardiol"},{"key":"10568_CR215","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.amjcard.2017.11.048","volume":"121","author":"M Eug\u00e8ne","year":"2018","unstructured":"Eug\u00e8ne M, Urena M, Abtan J, Carrasco J-L, Ghodbane W, Nataf P, Vahanian A, Himbert D (2018) Effectiveness of rescue percutaneous balloon aortic valvuloplasty in patients with severe aortic stenosis and acute heart failure. Am J Cardiol 121:746\u2013750","journal-title":"Am J Cardiol"},{"key":"10568_CR216","doi-asserted-by":"crossref","unstructured":"Varela ML, Teixeira P, Ponte M, Caeiro D, Dias A, Rodrigues A, Braga P (2019) Balloon aortic valvuloplasty in patients admitted for cardiogenic shock with severe aortic stenosis: a retrospective analysis of 14 cases. Cureus","DOI":"10.7759\/cureus.5407"},{"issue":"5","key":"10568_CR217","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/24748706.2021.1954274","volume":"5","author":"A Kumar","year":"2021","unstructured":"Kumar A, Shah R, Young LD, Patel DR, Bansal A, Popovic ZB, Menon V, Kalra A, Tuzcu EM, White J, Puri R, Krishnaswamy A, Kapadia SR, Reed GW (2021) Safety and efficacy of balloon aortic valvuloplasty stratified by acuity of patient illness. Struct Heart 5(5):520\u2013529","journal-title":"Struct Heart"},{"key":"10568_CR218","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00380-023-02243-y","volume":"38","author":"A Kilias","year":"2023","unstructured":"Kilias A, Stefanou M-I, Steeg M, Plachtzik C, Kirchner J, Walkowiak T, Bocksch W (2023) Rescue aortic valvuloplasty for severe aortic stenosis is simple and effective in severely hemodynamically compromised patients presenting to centers without on-site heart surgery or TAVI facilities. Heart Vessels 38:957\u2013963","journal-title":"Heart Vessels"},{"key":"10568_CR219","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/heartjnl-2016-311037","volume":"104","author":"D Bongiovanni","year":"2018","unstructured":"Bongiovanni D, K\u00fchl C, Bleiziffer S, Stecher L, Poch F, Greif M, Mehilli J, Massberg S, Frey N, Lange R, Laugwitz K-L, Schymik G, Frank D, Kupatt C (2018) Emergency treatment of decompensated aortic stenosis. Heart 104:23\u201329","journal-title":"Heart"},{"key":"10568_CR220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/clc.4960240308","volume":"24","author":"AB Buchwald","year":"2001","unstructured":"Buchwald AB, Meyer T, Scholz K, Schorn B, Unterberg C (2001) Efficacy of balloon valvuloplasty in patients with critical aortic stenosis and cardiogenic shock\u2013the role of shock duration. Clin Cardiol 24:214\u2013218","journal-title":"Clin Cardiol"},{"key":"10568_CR221","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0735-1097(94)90592-4","volume":"23","author":"PR Moreno","year":"1994","unstructured":"Moreno PR, Jang IK, Newell JB, Block PC, Palacios IF (1994) The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol 23:1071\u20131075","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR222","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001330","volume":"7","author":"A Bularga","year":"2020","unstructured":"Bularga A, Bing R, Shah AS, Adamson PD, Behan M, Newby DE, Flapan A, Uren N, Cruden N (2020) Clinical outcomes following balloon aortic valvuloplasty. Open Heart 7:e001330","journal-title":"Open Heart"},{"key":"10568_CR223","first-page":"607","volume":"98","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty S, Patel N, Bandyopadhyay D, Hajra A, Amgai B, Zaid S, Sharedalal P, Ahmad H, Cohen MB, Abbott JD, Naidu SS (2021) Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock. Catheter Cardiovasc Interv 98:607\u2013612","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR224","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10741-023-10372-9","volume":"29","author":"B Patel","year":"2024","unstructured":"Patel B, D\u2019Souza S, Sahni T, Yehya A (2024) Pulmonary hypertension secondary to valvular heart disease: a state-of-the-art review. Heart Fail Rev 29:277\u2013286","journal-title":"Heart Fail Rev"},{"key":"10568_CR225","first-page":"115","volume":"36","author":"V Maheshwari","year":"2018","unstructured":"Maheshwari V, Barr B, Srivastava M (2018) Acute valvular heart disease. Cardiol Clin 36:115\u2013127","journal-title":"Cardiol Clin"},{"key":"10568_CR226","volume":"21","author":"NC Wunderlich","year":"2019","unstructured":"Wunderlich NC, Dalvi B, Ho SY, K\u00fcx H, Siegel RJ (2019) Rheumatic mitral valve stenosis: diagnosis and treatment options. Curr Cardiol Rep 21:14","journal-title":"Curr Cardiol Rep"},{"key":"10568_CR227","volume":"7","author":"S Jalil","year":"2023","unstructured":"Jalil S, Ahmed A, Abdalla M, Al-Hijji M (2023) Severe mitral stenosis masquerading as cardiogenic shock successfully managed with extracorporeal membrane oxygenation and percutaneous mitral commissurotomy: a case report. Eur Heart J 7:ytad553","journal-title":"Eur Heart J"},{"key":"10568_CR228","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1051\/ject\/200739112","volume":"39","author":"G Fayad","year":"2007","unstructured":"Fayad G, Larrue B, Modine T, Azzaoui R, Regnault A, Koussa M, Gourlay T, Fourrier F, Decoene C, Warembourg H (2007) Extracorporeal membrane oxygenation in severe acute respiratory failure in postpartum woman with rheumatic mitral valve disease: benefit, factors furthering the success of this procedure, and review of the literature. J Extra Corpor Technol 39:112\u2013116","journal-title":"J Extra Corpor Technol"},{"key":"10568_CR229","first-page":"385","volume":"4","author":"RM Clark","year":"2022","unstructured":"Clark RM, Bruoha S, Milwidsky A, Ho E, Murthy S, Chau ML, Latib A, Jorde UP (2022) Venoarterial extracorporeal membrane oxygenation to facilitate transcutaneous mitral valve replacement in critical mitral stenosis. JACC: Case Reports 4:385\u2013390","journal-title":"JACC: Case Reports"},{"key":"10568_CR230","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0735-1097(98)00215-0","volume":"32","author":"YY Lokhandwala","year":"1998","unstructured":"Lokhandwala YY, Banker D, Vora AM, Kerkar PG, Deshpande JR, Kulkarni HL, Dalvi BV (1998) Emergent balloon mitral valvotomy in patients presenting with cardiac arrest, cardiogenic shock or refractory pulmonary edema. J Am Coll Cardiol 32:154\u2013158","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR231","first-page":"602","volume":"8","author":"V Galusko","year":"2022","unstructured":"Galusko V, Ionescu A, Edwards A, Sekar B, Wong K, Patel K, Lloyd G, Ricci F, Khanji MY (2022) Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations. Eur Heart J 8:602\u2013618","journal-title":"Eur Heart J"},{"key":"10568_CR232","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/joic.12507","volume":"31","author":"A Ananthakrishna Pillai","year":"2018","unstructured":"Ananthakrishna Pillai A, Ramasamy C, V SG, Kottyath H (2018) Outcomes following balloon mitral valvuloplasty in pregnant females with mitral stenosis and significant sub valve disease with severe decompensated heart failure. J Interv Cardiol 31:525\u2013531","journal-title":"J Interv Cardiol"},{"key":"10568_CR233","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/0971-9784.38785","volume":"7","author":"MC Kapoor","year":"2004","unstructured":"Kapoor MC, Dugal JS, Sharma S, Singh S (2004) Percutaneous transvenous mitral commissurotomy\u2013a life saving option in severe mitral stenosis with cardiogenic shock. Ann Card Anaesth 7:158\u2013161","journal-title":"Ann Card Anaesth"},{"key":"10568_CR234","first-page":"752","volume":"13","author":"J Endrys","year":"2001","unstructured":"Endrys J, Habashy AG, Hayat N (2001) Life-saving balloon mitral valvuloplasty in patient with cardiogenic shock after cardiac arrest. J Invasive Cardiol 13:752\u2013754","journal-title":"J Invasive Cardiol"},{"key":"10568_CR235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.hlc.2007.12.008","volume":"18","author":"M Notrica","year":"2009","unstructured":"Notrica M, Wisner J, Villagra L, Rossini A, Gonzalia D, Adaro M, Zillo A, Izcovich E, Albertal M (2009) Life-saving percutaneous mitral valvuloplasty on a pregnant woman with refractory cardiogenic shock. Heart Lung Circ 18:301\u2013304","journal-title":"Heart Lung Circ"},{"key":"10568_CR236","first-page":"195","volume":"43","author":"JH Goldman","year":"1998","unstructured":"Goldman JH, Slade A, Clague J (1998) Cardiogenic shock secondary to mitral stenosis treated by balloon mitral valvuloplasty. Cathet Cardiovasc Diagn 43:195\u2013197","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10568_CR237","first-page":"18","volume":"31","author":"JJ Wu","year":"1994","unstructured":"Wu JJ, Chern MS, Yeh KH, Chen YC, Fu M, Hung JS (1994) Urgent\/emergent percutaneous transvenous mitral commissurotomy. Cathet Cardiovasc Diagn 31:18\u201322","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10568_CR238","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/hrt.73.6.555","volume":"73","author":"JJ Patel","year":"1995","unstructured":"Patel JJ, Munclinger MJ, Mitha AS, Patel N (1995) Percutaneous balloon dilatation of the mitral valve in critically ill young patients with intractable heart failure. Br Heart J 73:555\u2013558","journal-title":"Br Heart J"},{"key":"10568_CR239","doi-asserted-by":"crossref","first-page":"96","DOI":"10.21037\/acs-2019-mv-169","volume":"10","author":"L Pirelli","year":"2021","unstructured":"Pirelli L, Hong E, Steffen R, Vahl TP, Kodali SK, Bapat V (2021) Mitral valve-in-valve and valve-in-ring: tips, tricks, and outcomes. Ann Cardiothorac Surg 10:96\u2013112","journal-title":"Ann Cardiothorac Surg"},{"key":"10568_CR240","doi-asserted-by":"crossref","first-page":"Y93","DOI":"10.4244\/EIJV12SYA25","volume":"12","author":"D Dvir","year":"2016","unstructured":"Dvir D, Webb J (2016) Mitral valve-in-valve and valve-in-ring: technical aspects and procedural outcomes. EuroIntervention 12:Y93\u2013Y96","journal-title":"EuroIntervention"},{"key":"10568_CR241","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.jacc.2021.04.051","volume":"77","author":"A Alperi","year":"2021","unstructured":"Alperi A, Granada JF, Bernier M, Dagenais F, Rod\u00e9s-Cabau J (2021) Current status and future prospects of transcatheter mitral valve replacement. J Am Coll Cardiol 77:3058\u20133078","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR242","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.639058","author":"F Kargoli","year":"2021","unstructured":"Kargoli F, Pagnesi M, Rahgozar K, Goldberg Y, Ho E, Chau M, Colombo A, Latib A (2021) Current devices and complications related to transcatheter mitral valve replacement: the bumpy road to the top. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.639058","journal-title":"Front Cardiovasc Med"},{"key":"10568_CR243","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cpcardiol.2017.10.004","volume":"43","author":"OA Akinseye","year":"2018","unstructured":"Akinseye OA, Pathak A, Ibebuogu UN (2018) Aortic valve regurgitation: a comprehensive review. Curr Probl Cardiol 43:315\u2013334","journal-title":"Curr Probl Cardiol"},{"key":"10568_CR244","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-019-1144-6","volume":"21","author":"N Flint","year":"2019","unstructured":"Flint N, Wunderlich NC, Shmueli H, Ben-Zekry S, Siegel RJ, Beigel R (2019) Aortic regurgitation. Curr Cardiol Rep 21:65","journal-title":"Curr Cardiol Rep"},{"key":"10568_CR245","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0002-9149(76)80003-3","volume":"38","author":"RR Miller","year":"1976","unstructured":"Miller RR, Vismara LA, DeMaria AN, Salel AF, Mason DT (1976) Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume. Am J Cardiol 38:564\u2013567","journal-title":"Am J Cardiol"},{"key":"10568_CR246","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.jcin.2016.08.049","volume":"9","author":"A Franzone","year":"2016","unstructured":"Franzone A, Piccolo R, Siontis GCM, Lanz J, Stortecky S, Praz F, Roost E, Vollenbroich R, Windecker S, Pilgrim T (2016) Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review. JACC Cardiovasc Interv 9:2308\u20132317","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR247","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.4244\/EIJ-D-24-00339","volume":"20","author":"R Le Ruz","year":"2024","unstructured":"Le Ruz R, Leroux L, Lhermusier T, Cuisset T, Van Belle E, Dibie A, Palermo V, Champagnac D, Obadia J-F, Teiger E, Ohlman P, Tch\u00e9tch\u00e9 D, Le Breton H, Saint-Etienne C, Piriou P-G, Plessis J, Beurtheret S, Du Chayla F, Lecl\u00e8re M, Lef\u00e8vre T, Collet J-P, Eltchaninoff H, Gilard M, Iung B, Manigold T, Letocart V, Of Stop-As And France-Tavi Investigators OB (2024) Outcomes of transcatheter aortic valve implantation for native aortic valve regurgitation. EuroIntervention 20:e1076\u2013e1085","journal-title":"EuroIntervention"},{"key":"10568_CR248","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.acvd.2022.12.003","volume":"116","author":"C Delhomme","year":"2023","unstructured":"Delhomme C, Urena M, Zouaghi O, Campelo-Parada F, Ohlmann P, Rioufol G, Van BE, Pinaud F, Meneveau N, Staat P, Morel O, Derimay F, Vincent F, Rouleau F, Brochet E, Chong-Nguyen C, Himbert D (2023) Transcatheter aortic valve implantation using the SAPIEN 3 valve to treat aortic regurgitation: the French multicentre S3AR study. Arch Cardiovasc Dis 116:98\u2013105","journal-title":"Arch Cardiovasc Dis"},{"key":"10568_CR249","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2017.03.004","volume":"10","author":"FJ Sawaya","year":"2017","unstructured":"Sawaya FJ, Deutsch M-A, Seiffert M, Yoon S-H, Codner P, Wickramarachchi U, Latib A, Petronio AS, Rod\u00e9s-Cabau J, Taramasso M, Spaziano M, Bosmans J, Biasco L, Mylotte D, Savontaus M, Gheeraert P, Chan J, J\u00f8rgensen TH, Sievert H, Mocetti M, Lef\u00e8vre T, Maisano F, Mangieri A, Hildick-Smith D, Kornowski R, Makkar R, Bleiziffer S, S\u00f8ndergaard L, De Backer O (2017) Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study. JACC Cardiovasc Interv 10:1048\u20131056","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR250","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.amjcard.2018.05.044","volume":"122","author":"OD Backer","year":"2018","unstructured":"Backer OD, Pilgrim T, Simonato M, Mackensen GB, Fiorina C, Veulemanns V, Cerillo A, Schofer J, Amabile N, Achkouty G, Sch\u00e4fer U, Deutsch M-A, Sinning J-M, Rahman MS, Sawaya FJ, Hildick-Smith D, Hernandez JM, Kim W-K, Lefevre T, Seiffert M, Bleiziffer S, Petronio AS, Mieghem NV, Taramasso M, S\u00f8ndergaard L, Windecker S, Latib A, Dvir D (2018) Usefulness of transcatheter aortic valve implantation for treatment of pure native aortic valve regurgitation. Am J Cardiol 122:1028\u20131035","journal-title":"Am J Cardiol"},{"key":"10568_CR251","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.jacc.2017.10.006","volume":"70","author":"S-H Yoon","year":"2017","unstructured":"Yoon S-H, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, Yzeiraj E, Amat-Santos IJ, Tchetche D, Jung C, Fujita B, Mangieri A, Deutsch M-A, Ubben T, Deuschl F, Kuwata S, De BC, Williams T, Dhoble A, Kim W-K, Ferrari E, Barbanti M, Vollema EM, Miceli A, Giannini C, Attizzani GF, Kong WKF, Gutierrez-Ibanes E, Jimenez Diaz VA, Wijeysundera HC, Kaneko H, Chakravarty T, Makar M, Sievert H, Hengstenberg C, Prendergast BD, Vincent F, Abdel-Wahab M, Nombela-Franco L, Silaschi M, Tarantini G, Butter C, Ensminger SM, Hildick-Smith D, Petronio AS, Yin W-H, De MF, Testa L, Van MNM, Whisenant BK, Kuck K-H, Colombo A, Kar S, Moris C, Delgado V, Maisano F, Nietlispach F, Mack MJ, Schofer J, Schaefer U, Bax JJ, Frerker C, Latib A, Makkar RR (2017) Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol 70:2752\u20132763","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR252","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(23)02806-4","volume":"403","author":"TP Vahl","year":"2024","unstructured":"Vahl TP, Thourani VH, Makkar RR, Hamid N, Khalique OK, Daniels D, McCabe JM, Satler L, Russo M, Cheng W, George I, Aldea G, Sheridan B, Kereiakes D, Golwala H, Zahr F, Chetcuti S, Yadav P, Kodali SK, Treede H, Baldus S, Amoroso N, Ranard LS, Pinto DS, Leon MB (2024) Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study. Lancet 403:1451\u20131459","journal-title":"Lancet"},{"key":"10568_CR253","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jcin.2023.05.018","volume":"16","author":"S Garcia","year":"2023","unstructured":"Garcia S, Ye J, Webb J, Reardon M, Kleiman N, Goel S, Hatab T, Fam N, Peterson M, Liauw S, Frisoli TM, Bashir H, Paige D, Rock D, Schmidt C, Jollis JG, Kereiakes DJ (2023) Transcatheter treatment of native aortic valve regurgitation: the North American experience with a novel device. JACC Cardiovasc Interv 16:1953\u20131960","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR254","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.amjcard.2017.11.042","volume":"121","author":"G Pesarini","year":"2018","unstructured":"Pesarini G, Lunardi M, Piccoli A, Gottin L, Prati D, Ferrero V, Scarsini R, Milano A, Forni A, Faggian G, Ribichini F (2018) Effectiveness and safety of transcatheter aortic valve implantation in patients with pure aortic regurgitation and advanced heart failure. Am J Cardiol 121:642\u2013648","journal-title":"Am J Cardiol"},{"key":"10568_CR255","volume":"89","author":"G Dall\u2019Ara","year":"2017","unstructured":"Dall\u2019Ara G, Saia F, Moretti C, Marrozzini C, Taglieri N, Bordoni B, Chiarabelli M, Ciuca C, Rapezzi C, Marzocchi A (2017) Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty. Catheter Cardiovasc Interv 89:E145\u2013E152","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR256","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2459\/JCM.0000000000000873","volume":"21","author":"L Branca","year":"2020","unstructured":"Branca L, Adamo M, Fiorina C, Ettori F, Chizzola G, Scodro M, Masini G, Papa I, Metra M, Curello S (2020) Life-saving transcatheter aortic valve implantation for acute severe aortic regurgitation due to rheumatoid arthritis and complicated by cardiogenic shock. J Cardiovasc Med (Hagerstown) 21:268\u2013271","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10568_CR257","first-page":"276","volume":"4","author":"M Chiang","year":"2022","unstructured":"Chiang M, Gonzalez PE, O\u2019Neill BP, Lee J, Frisoli T, Wang DD, O\u2019Neill WW, Villablanca PA (2022) Left atrial venoarterial extracorporeal membrane oxygenation for acute aortic regurgitation and cardiogenic shock. JACC: Case Reports 4:276\u2013279","journal-title":"JACC: Case Reports"},{"key":"10568_CR258","volume":"6","author":"E Ballout","year":"2022","unstructured":"Ballout E, Combaret N, Riocreux C, Souteyrand G (2022) Leaflet disruption of ViV-TAVI after bioprosthetic valve fracture leading to severe aortic regurgitation: a case report. Eur Heart J 6:ytac313","journal-title":"Eur Heart J"},{"key":"10568_CR259","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jocs.14441","volume":"35","author":"AS Fathi","year":"2020","unstructured":"Fathi AS, Ali JM, Mann S, Taghavi J, Davies WR, Sudarshan C (2020) Emergency valve-in-valve transcatheter aortic valve implantation for endocarditis degeneration. J Card Surg 35:713\u2013715","journal-title":"J Card Surg"},{"key":"10568_CR260","volume":"2018","author":"ID Hanson","year":"2018","unstructured":"Hanson ID, Dalal PK, Renard BM, Hanzel GS, Vivacqua A (2018) Emergency valve-in-valve transcatheter aortic valve implantation for the treatment of acute stentless bioprosthetic aortic insufficiency and cardiogenic shock. Case Rep Cardiol 2018:6872748","journal-title":"Case Rep Cardiol"},{"key":"10568_CR261","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ehjci\/jey055","volume":"19","author":"J Hamudi","year":"2018","unstructured":"Hamudi J, Jaffe R, Khader N, Adawi S, Shiran A (2018) Transoesophageal echocardiography guided emergency valve-in-valve transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 19:713","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10568_CR262","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.athoracsur.2018.02.022","volume":"106","author":"JM Trahanas","year":"2018","unstructured":"Trahanas JM, Van BBS, Miller SE, Irobunda C, Kodali SK, George I (2018) Emergent transcatheter aortic valve replacement for aortic insufficiency. Ann Thorac Surg 106:e7\u2013e9","journal-title":"Ann Thorac Surg"},{"key":"10568_CR263","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.carrev.2018.11.007","volume":"19","author":"M Iantorno","year":"2018","unstructured":"Iantorno M, Ben-Dor I, Rogers T, Gajanana D, Attaran S, Buchanan KD, Satler LF, Shults CC, Thourani VH, Waksman R (2018) Emergent valve-in-valve transcatheter aortic valve replacement in patient with acute aortic regurgitation and cardiogenic shock with preoperative extracorporeal membrane oxygenator: a case report and review of the literature. Cardiovasc Revasc Med 19:68\u201370","journal-title":"Cardiovasc Revasc Med"},{"key":"10568_CR264","first-page":"625","volume":"25","author":"M Fudim","year":"2013","unstructured":"Fudim M, Markley RR, Robbins MA (2013) Transcatheter aortic valve replacement for aortic bioprosthetic valve failure with cardiogenic shock. J Invasive Cardiol 25:625\u2013626","journal-title":"J Invasive Cardiol"},{"issue":"3","key":"10568_CR265","first-page":"342.e5","volume":"34","author":"G Achkouty","year":"2018","unstructured":"Achkouty G, Amabile N, Zannis K, Veugeois A, Caussin C (2018) Transcatheter aortic valve replacement for severe aortic regurgitation with acute refractory cardiogenic shock. Can J Cardiol 34(3):342.e5-342.e7","journal-title":"Can J Cardiol"},{"key":"10568_CR266","doi-asserted-by":"crossref","unstructured":"Simonato M, Palma JH, Alirhayim Z, Guddeti R, Kaneko T, Garcia S (2024) The essential aortic valve-in-valve transcatheter aortic valve replacement update: procedural strategies and current clinical results. Structural Heart 100318","DOI":"10.1016\/j.shj.2024.100318"},{"issue":"9","key":"10568_CR267","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4244\/EIJ-D-21-00157","volume":"17","author":"G Tarantini","year":"2021","unstructured":"Tarantini G, Dvir D, Tang GHL (2021) Transcatheter aortic valve implantation in degenerated surgical aortic valves. EuroIntervention 17(9):709\u2013719","journal-title":"EuroIntervention"},{"key":"10568_CR268","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005\u20131011","journal-title":"Lancet"},{"key":"10568_CR269","first-page":"275","volume":"21","author":"CE Strauss","year":"2012","unstructured":"Strauss CE, Duval S, Pastorius D, Harris KM (2012) Pharmacotherapy in the treatment of mitral regurgitation: a systematic review. J Heart Valve Dis 21:275\u2013285","journal-title":"J Heart Valve Dis"},{"key":"10568_CR270","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.amjmed.2018.01.048","volume":"131","author":"Y Sandoval","year":"2018","unstructured":"Sandoval Y, Sorajja P, Harris KM (2018) Contemporary management of ischemic mitral regurgitation: a review. Am J Med 131:887\u2013895","journal-title":"Am J Med"},{"issue":"3","key":"10568_CR271","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-83-3-312","volume":"83","author":"CW Harshaw","year":"1975","unstructured":"Harshaw CW, Grossman W, Munro AB, McLaurin LP (1975) Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin. Ann Intern Med 83(3):312\u2013316","journal-title":"Ann Intern Med"},{"key":"10568_CR272","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.CIR.50.5.1025","volume":"50","author":"DJ Goodman","year":"1974","unstructured":"Goodman DJ, Rossen RM, Holloway EL, Alderman EL, Harrison DC (1974) Effect of nitroprusside on left ventricular dynamics in mitral regurgitation. Circulation 50:1025\u20131032","journal-title":"Circulation"},{"key":"10568_CR273","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0002-9149(79)90077-8","volume":"43","author":"C Yoran","year":"1979","unstructured":"Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RW, Sonnenblick EH (1979) Mechanism of reduction of mitral regurgitation with vasodilator therapy. Am J Cardiol 43:773\u2013777","journal-title":"Am J Cardiol"},{"key":"10568_CR274","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/0002-8703(89)90588-7","volume":"118","author":"G Keren","year":"1989","unstructured":"Keren G, Laniado S, Sonnenblick EH, Lejemtel TH (1989) Dynamics of functional mitral regurgitation during dobutamine therapy in patients with severe congestive heart failure: a Doppler echocardiographic study. Am Heart J 118:748\u2013754","journal-title":"Am Heart J"},{"key":"10568_CR275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1540-8175.1998.tb00573.x","volume":"15","author":"M Sonoda","year":"1998","unstructured":"Sonoda M, Takenaka K, Sakamoto T, Watanabe F, Nakajima Y, Yang WD, Omata M (1998) Effects of dobutamine infusion on mitral regurgitation. Echocardiography 15:13\u201320","journal-title":"Echocardiography"},{"key":"10568_CR276","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2459\/JCM.0b013e32833832f6","volume":"11","author":"G Branzi","year":"2010","unstructured":"Branzi G, Malfatto G, Villani A, Ciambellotti F, Revera M, Giglio A, Rosa FD, Facchini M, Parati G (2010) Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure. J Cardiovasc Med 11:662\u2013668","journal-title":"J Cardiovasc Med"},{"key":"10568_CR277","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehx580","volume":"39","author":"J Masip","year":"2018","unstructured":"Masip J, Peacock WF, Price S, Cullen L, Martin-Sanchez FJ, Seferovic P, Maisel AS, Miro O, Filippatos G, Vrints C, Christ M, Cowie M, Platz E, McMurray J, DiSomma S, Zeymer U, Bueno H, Gale CP, Lettino M, Tavares M, Ruschitzka F, Mebazaa A, Harjola V-P, Mueller C (2018) Indications and practical approach to non-invasive ventilation in acute heart failure. Eur Heart J 39:17\u201325","journal-title":"Eur Heart J"},{"key":"10568_CR278","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00024382-200304000-00007","volume":"19","author":"ALAJ Dekker","year":"2003","unstructured":"Dekker ALAJ, Reesink KD, van der Veen FH, van Ommen GVA, Geskes GG, Soemers ACM, Maessen JG (2003) Intra-aortic balloon pumping in acute mitral regurgitation reduces aortic impedance and regurgitant fraction. Shock 19:334\u2013338","journal-title":"Shock"},{"key":"10568_CR279","first-page":"1129","volume":"79","author":"L Harmon","year":"2012","unstructured":"Harmon L, Boccalandro F (2012) Cardiogenic shock secondary to severe acute ischemic mitral regurgitation managed with an Impella 2.5 percutaneous left ventricular assist device. Catheter Cardiovasc Interv 79:1129\u20131134","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR280","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-219749","author":"B Jalil","year":"2017","unstructured":"Jalil B, El-Kersh K, Frizzell J, Ahmed S (2017) Impella percutaneous left ventricular assist device for severe acute ischaemic mitral regurgitation as a bridge to surgery. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2017-219749","journal-title":"BMJ Case Rep"},{"key":"10568_CR281","doi-asserted-by":"crossref","DOI":"10.1186\/s13019-024-03019-9","volume":"19","author":"I Dumitru","year":"2024","unstructured":"Dumitru I, Uysal A, Shoemaker J, Sevillano M, Schnell L, Vasaiwala S, Ali SO (2024) Impella 5.5 as a bridge-to-surgery in acute ischemic mitral regurgitation post-percutaneous coronary intervention: a case report. J Cardiothorac Surg 19:626","journal-title":"J Cardiothorac Surg"},{"key":"10568_CR282","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1536\/ihj.22-572","volume":"64","author":"J Nakata","year":"2023","unstructured":"Nakata J, Saku K, Nishikawa T, Kimura T, Sangen H, Asano K, Kadooka K, Hosokawa Y, Tara S, Shimizu W, Yamamoto T, Asai K (2023) Substantial reduction of acute ischemic mitral regurgitation using Impella in AMI complicated with cardiogenic shock. Int Heart J 64:294\u2013298","journal-title":"Int Heart J"},{"key":"10568_CR283","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ehjacc\/zuaa031","volume":"10","author":"C Vandenbriele","year":"2021","unstructured":"Vandenbriele C, Balthazar T, Wilson J, Adriaenssens T, Davies S, Droogne W, Dubois C, Caetano AF, Goetschalckx K, Jacobs S, Janssens S, Ledot S, Meyns B, Soliman-Aboumarie H, Verbrugghe P, Price S (2021) Left Impella\u00ae-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to MitraClip\u00ae-procedure: a new option for critically ill patients. European Heart Journal. Acute Cardiovascular Care 10:415\u2013421","journal-title":"European Heart Journal. Acute Cardiovascular Care"},{"key":"10568_CR284","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1253\/circrep.CR-21-0016","volume":"3","author":"S Imaoka","year":"2021","unstructured":"Imaoka S, Kainuma S, Toda K, Miyagawa S, Yoshioka D, Kawamura T, Kawamura A, Kashiyama N, Nakamoto K, Takeda Y, Sakata Y, Sawa Y (2021) Impella support as a bridge to surgery for severe mitral regurgitation with cardiogenic shock. Circ Rep 3:178\u2013181","journal-title":"Circ Rep"},{"key":"10568_CR285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjcard.2024.11.005","volume":"236","author":"PA Villablanca","year":"2025","unstructured":"Villablanca PA, Fadel RA, Giustino G, Jabri A, Basir MB, Cowger J, Alaswad K, O\u2019Neill B, Gonzalez PE, Gyzm GG, Frisoli T, Lee J, Aurora L, Gorgis S, Nemeh H, Apostolou D, Alqarqaz M, Koenig GC, Aronow HD, Fuller B, Aggarwal V, O\u2019Neill W (2025) Hemodynamic effects and clinical outcomes of left atrial veno-arterial extracorporeal membrane oxygenation (LAVA-ECMO) in cardiogenic shock. Am J Cardiol 236:79\u201385","journal-title":"Am J Cardiol"},{"key":"10568_CR286","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.4244\/EIJ-D-19-00653","volume":"15","author":"R Estevez-Loureiro","year":"2020","unstructured":"Estevez-Loureiro R, Adamo M, Arzamendi D, Denti P, Freixa X, Nombela-Franco L, Pascual I, Melica B, Attias D, Serrador A, Benito-Gonz\u00e1lez T, I\u00f1iguez A, Fern\u00e1ndez-V\u00e1zquez F (2020) Transcatheter mitral valve repair in patients with acute myocardial infarction: insights from the European Registry of MitraClip in Acute Mitral Regurgitation following an acute myocardial infarction (EREMMI). EuroIntervention 15:1248\u20131250","journal-title":"EuroIntervention"},{"key":"10568_CR287","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijcard.2017.02.072","volume":"234","author":"M Adamo","year":"2017","unstructured":"Adamo M, Curello S, Chiari E, Fiorina C, Chizzola G, Magatelli M, Locantore E, Cuminetti G, Lombardi C, Manzato A, Metra M, Ettori F (2017) Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: a single centre experience. Int J Cardiol 234:53\u201357","journal-title":"Int J Cardiol"},{"key":"10568_CR288","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/eurheartj\/ehab496","volume":"43","author":"D Haberman","year":"2022","unstructured":"Haberman D, Est\u00e9vez-Loureiro R, Benito-Gonzalez T, Denti P, Arzamendi D, Adamo M, Freixa X, Nombela-Franco L, Villablanca P, Krivoshei L, Fam N, Spargias K, Czarnecki A, Pascual I, Praz F, Sudarsky D, Kerner A, Ninios V, Gennari M, Beeri R, Perl L, Wasserstrum Y, Danenberg H, Poles L, George J, Caneiro-Queija B, Scianna S, Moaraf I, Schiavi D, Scardino C, Corpataux N, Echarte-Morales J, Chrissoheris M, Fern\u00e1ndez-Peregrina E, Pasquale MD, Regueiro A, Vergara-Uzcategui C, I\u00f1iguez-Romo A, Fern\u00e1ndez-V\u00e1zquez F, Dvir D, Maisano F, Taramasso M, Shuvy M (2022) Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction. Eur Heart J 43:641\u2013650","journal-title":"Eur Heart J"},{"key":"10568_CR289","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/ejhf.1565","volume":"21","author":"D Haberman","year":"2019","unstructured":"Haberman D, Taramasso M, Czarnecki A, Kerner A, Chrissoheris M, Spargias K, Poles L, Agmon Y, Scianna S, Beeri R, Lotan C, Maisano F, Shuvy M (2019) Salvage MitraClip in severe secondary mitral regurgitation complicating acute myocardial infarction: data from a multicentre international study. Eur J Heart Fail 21:1161\u20131164","journal-title":"Eur J Heart Fail"},{"key":"10568_CR290","first-page":"1604.e5","volume":"35","author":"I Komatsu","year":"2019","unstructured":"Komatsu I, Cohen EA, Cohen GN, Czarnecki A (2019) Transcatheter mitral valve edge-to-edge repair with the new MitraClip XTR system for acute mitral regurgitation caused by papillary muscle rupture. Can J Cardiol 35:1604.e5-1604.e7","journal-title":"Can J Cardiol"},{"key":"10568_CR291","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2014.09.075","volume":"99","author":"E Bahlmann","year":"2015","unstructured":"Bahlmann E, Frerker C, Kreidel F, Thielsen T, Ghanem A, van der Schalk H, Grahn H, Kuck K-H (2015) Mitraclip implantation after acute ischemic papillary muscle rupture in a patient with prolonged cardiogenic shock. Ann Thorac Surg 99:e41\u2013e42","journal-title":"Ann Thorac Surg"},{"key":"10568_CR292","first-page":"1461.e13","volume":"30","author":"R Wolff","year":"2014","unstructured":"Wolff R, Cohen G, Peterson C, Wong S, Hockman E, Lo J, Strauss BH, Cohen EA (2014) Mitraclip for papillary muscle rupture in patient with cardiogenic shock. Can J Cardiol 30:1461.e13-1461.e14","journal-title":"Can J Cardiol"},{"key":"10568_CR293","volume":"98","author":"G Falasconi","year":"2021","unstructured":"Falasconi G, Melillo F, Pannone L, Adamo M, Ronco F, Latib A, Rahgozar K, Carrabba N, Valenti R, Citro R, Stella S, Ingallina G, Capogrosso C, Scandroglio M, Ancona F, Godino C, Denti P, Castiglioni A, Bonis MD, Colombo A, Lupi L, Branca L, Montorfano M, Agricola E (2021) Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: a multicenter observational experience (MITRA-SHOCK study). Catheter Cardiovasc Interv 98:E163\u2013E170","journal-title":"Catheter Cardiovasc Interv"},{"key":"10568_CR294","volume":"10","author":"GHL Tang","year":"2021","unstructured":"Tang GHL, Estevez-Loureiro R, Yu Y, Prillinger JB, Zaid S, Psotka MA (2021) Survival following edge-to-edge transcatheter mitral valve repair in patients with cardiogenic shock: a nationwide analysis. J Am Heart Assoc 10:e019882","journal-title":"J Am Heart Assoc"},{"key":"10568_CR295","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-23-00904","volume":"20","author":"L Conradi","year":"2024","unstructured":"Conradi L, Ludwig S, Sorajja P, Duncan A, Bethea B, Dahle G, Babaliaros V, Guerrero M, Thourani V, Dumonteil N, Modine T, Garatti A, Denti P, Leipsic J, Chuang ML, Blanke P, Muller DW, Badhwar V (2024) Clinical outcomes and predictors of transapical transcatheter mitral valve replacement: the Tendyne expanded clinical study. EuroIntervention 20:e887\u2013e897","journal-title":"EuroIntervention"},{"key":"10568_CR296","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jcin.2024.10.018","volume":"18","author":"D Samim","year":"2025","unstructured":"Samim D, Sorajja P, Lanz J, Stolz L, Angellotti D, Hausleiter J, Ruge H, Kuhn EW, Baldus S, Ochs L, Ueyama HA, Babaliaros V, Greenbaum AB, G\u00f6ssl M, Januska J, Alreshidan M, Reineke D, Windecker S, Adam M, Praz F (2025) Transapical transcatheter mitral valve replacement after failed transcatheter edge-to-edge repair: a multicenter experience. JACC Cardiovasc Interv 18:311\u2013321","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR297","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jcin.2023.12.027","volume":"17","author":"MM Hell","year":"2024","unstructured":"Hell MM, Wild MG, Baldus S, Rudolph T, Treede H, Petronio AS, Modine T, Andreas M, Coisne A, Duncan A, Franco LN, Praz F, Ruge H, Conradi L, Zierer A, Anselmi A, Dumonteil N, Nickenig G, Pi\u00f1\u00f3n M, Barth S, Adamo M, Dubois C, Torracca L, Maisano F, Lurz P, von Bardeleben RS, Hausleiter J, TENDER Investigators (2024) Transapical mitral valve replacement: 1-year results of the real-world Tendyne European Experience Registry. JACC Cardiovasc Interv 17:648\u2013661","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR298","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jcin.2024.02.033","volume":"17","author":"V Bapat","year":"2024","unstructured":"Bapat V, Weiss E, Bajwa T, Thourani VH, Yadav P, Thaden JJ, Lim DS, Reardon M, Pinney S, Adams DH, Yakubov SJ, Modine T, Redwood SR, Walton A, Spargias K, Zhang A, Mack M, Leon MB (2024) 2-year clinical and echocardiography follow-up of transcatheter mitral valve replacement with the transapical Intrepid system. JACC Cardiovasc Interv 17:1440\u20131451","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR299","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.jcin.2023.10.001","volume":"16","author":"F Zahr","year":"2023","unstructured":"Zahr F, Song HK, Chadderdon S, Gada H, Mumtaz M, Byrne T, Kirshner M, Sharma S, Kodali S, George I, Merhi W, Yarboro L, Sorajja P, Bapat V, Bajwa T, Weiss E, Thaden JJ, Gearhart E, Lim S, Reardon M, Adams D, Mack M, Leon MB (2023) 1-year outcomes following transfemoral transseptal transcatheter mitral valve replacement: intrepid TMVR early feasibility study results. JACC Cardiovasc Interv 16:2868\u20132879","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR300","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jcin.2024.10.018","volume":"18","author":"D Samim","year":"2025","unstructured":"Samim D, Sorajja P, Lanz J, Stolz L, Angellotti D, Hausleiter J, Ruge H, Kuhn EW, Baldus S, Ochs L, Ueyama HA, Babaliaros V, Greenbaum AB, G\u00f6ssl M, Januska J, Alreshidan M, Reineke D, Windecker S, Adam M, Praz F (2025) Transapical transcatheter mitral valve replacement after failed transcatheter edge-to-edge repair. JACC Cardiovasc Interv 18:311\u2013321","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR301","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.jacc.2021.08.060","volume":"78","author":"DWM Muller","year":"2021","unstructured":"Muller DWM, Sorajja P, Duncan A, Bethea B, Dahle G, Grayburn P, Babaliaros V, Guerrero M, Thourani VH, Bedogni F, Denti P, Dumonteil N, Modine T, Jansz P, Chuang ML, Blanke P, Leipsic J, Badhwar V (2021) 2-year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation. J Am Coll Cardiol 78:1847\u20131859","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR302","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4244\/EIJ-D-22-01037","volume":"19","author":"S Ludwig","year":"2023","unstructured":"Ludwig S, Perrin N, Coisne A, Ben AW, Weimann J, Adam M, Petronio AS, Dumonteil N, Sondergaard L, Adamo M, Regazzoli D, Garatti A, Schmidt T, Dahle G, Taramasso M, Walther T, Kempfert J, Obadia J-F, Chehab O, Tang GHL, Latib A, Goel SS, Fam NP, Andreas M, Muller DW, Denti P, Praz F, von Bardeleben RS, Granada JF, Modine T, Conradi L (2023) Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry. EuroIntervention 19:512\u2013525","journal-title":"EuroIntervention"},{"key":"10568_CR303","volume":"14","author":"M Barbanti","year":"2015","unstructured":"Barbanti M, Imm\u00e8 S, Grasso C (2015) Transcatheter mitral valve repair: a brief review. EuroIntervention 14:W42\u2013W44","journal-title":"EuroIntervention"},{"key":"10568_CR304","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jcin.2023.12.027","volume":"17","author":"MM Hell","year":"2024","unstructured":"Hell MM, Wild MG, Baldus S, Rudolph T, Treede H, Petronio AS, Modine T, Andreas M, Coisne A, Duncan A, Franco LN, Praz F, Ruge H, Conradi L, Zierer A, Anselmi A, Dumonteil N, Nickenig G, Pi\u00f1\u00f3n M, Barth S, Adamo M, Dubois C, Torracca L, Maisano F, Lurz P, von Bardeleben RS, Hausleiter J, Hell MM, Wild MG, Baldus S, Adam M, Rudolph T, Bleiziffer S, Treede H, Ruf TF, Petronio AS, Colli A, Giannini C, Modine T, Bonnet G, Andreas M, Kerbel T, Coisne A, Vincentelli A, Duncan A, Quarto C, Franco LN, Cobiella J, Praz F, Ruge H, Krane M, Conradi L, Ludwig S, Zierer A, Kellermair J, Damian I, Anselmi A, Donal E, Dumonteil N, Berthoumieu P, Nickenig G, Pi\u00f1\u00f3n M, Estevez R, Barth S, Reents W, Adamo M, Dubois C, Torracca L, Fumero A, Maisano F, Denti P, Bruxelles GA, Maes F, Kreidel F, Munguira JB, Musumeci F, Russo M, Monivas V, Walter T, Gherli R, Lurz P, Noack T, Hausleiter J, von Bardeleben RS (2024) Transapical mitral valve replacement. JACC Cardiovasc Interv 17:648\u2013661","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR305","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.jcin.2023.10.001","volume":"16","author":"F Zahr","year":"2023","unstructured":"Zahr F, Song HK, Chadderdon S, Gada H, Mumtaz M, Byrne T, Kirshner M, Sharma S, Kodali S, George I, Merhi W, Yarboro L, Sorajja P, Bapat V, Bajwa T, Weiss E, Thaden JJ, Gearhart E, Lim S, Reardon M, Adams D, Mack M, Leon MB (2023) 1-year outcomes following transfemoral transseptal transcatheter mitral valve replacement. JACC Cardiovasc Interv 16:2868\u20132879","journal-title":"JACC Cardiovasc Interv"},{"key":"10568_CR306","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527\u20131539","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR307","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jacc.2014.01.020","volume":"63","author":"LS Chawla","year":"2014","unstructured":"Chawla LS, Herzog CA, Costanzo MR, Tumlin J, Kellum JA, McCullough PA, Ronco C (2014) Proposal for a functional classification system of heart failure in patients with end-stage renal disease. J Am Coll Cardiol 63:1246\u20131252","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR308","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41581-020-00358-3","volume":"17","author":"R Murugan","year":"2021","unstructured":"Murugan R, Bellomo R, Palevsky PM, Kellum JA (2021) Ultrafiltration in critically ill patients treated with kidney replacement therapy. Nat Rev Nephrol 17:262\u2013276","journal-title":"Nat Rev Nephrol"},{"key":"10568_CR309","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5418","volume":"2","author":"R Murugan","year":"2019","unstructured":"Murugan R, Kerti SJ, Chang C-CH, Gallagher M, Clermont G, Palevsky PM, Kellum JA, Bellomo R (2019) Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open 2:e195418","journal-title":"JAMA Netw Open"},{"key":"10568_CR310","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2215\/CJN.0000000000000059","volume":"18","author":"MA Sahlawi","year":"2023","unstructured":"Sahlawi MA, Ponce D, Charytan DM, Cullis B, Perl J (2023) Peritoneal dialysis in critically ill patients. Clin J Am Soc Nephrol 18:512\u2013520","journal-title":"Clin J Am Soc Nephrol"},{"key":"10568_CR311","first-page":"649","volume":"4","author":"A Pandey","year":"2016","unstructured":"Pandey A, Golwala H, DeVore AD, Lu D, Madden G, Bhatt DL, Schulte PJ, Heidenreich PA, Yancy CW, Hernandez AF, Fonarow GC (2016) Trends in the use of guideline-directed therapies among dialysis patients hospitalized with systolic heart failure. JACC: Heart Failure 4:649\u2013661","journal-title":"JACC: Heart Failure"},{"key":"10568_CR312","volume":"77","author":"RB Patel","year":"2021","unstructured":"Patel RB, Fonarow G, Greene S, Zhang S, Alhanti B, DeVore A, Butler J, Heidenreich P, Huang J, Kittleson M, Maddox KJ, McDermott J, Owens A, Peterson P, Solomon S, Vardeny O, Yancy C, Vaduganathan M (2021) Clinical profiles, medical therapies, and outcomes among patients hospitalized for HF across the spectrum of kidney function: the GWTG-HF registry. J Am Coll Cardiol 77:559","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR313","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jjcc.2019.03.010","volume":"74","author":"H-Y Chang","year":"2019","unstructured":"Chang H-Y, Feng A-N, Fong M-C, Hsueh C-W, Lai W-T, Huang K-C, Chong E, Chen C-N, Chang H-C, Yin W-H (2019) Sacubitril\/valsartan in heart failure with reduced ejection fraction patients: real world experience on advanced chronic kidney disease, hypotension, and dose escalation. J Cardiol 74:372\u2013380","journal-title":"J Cardiol"},{"key":"10568_CR314","volume":"11","author":"C-Y Niu","year":"2022","unstructured":"Niu C-Y, Yang S-F, Ou S-M, Wu C-H, Huang P-H, Hung C-L, Lin C-C, Li S-Y (2022) Sacubitril\/valsartan in patients with heart failure and concomitant end-stage kidney disease. J Am Heart Assoc 11:e026407","journal-title":"J Am Heart Assoc"},{"key":"10568_CR315","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ehf2.12544","volume":"6","author":"A Heyse","year":"2019","unstructured":"Heyse A, Manhaeghe L, Mahieu E, Vanfraechem C, Van Durme F (2019) Sacubitril\/valsartan in heart failure and end-stage renal insufficiency. ESC Heart Fail 6:1331\u20131333","journal-title":"ESC Heart Fail"},{"key":"10568_CR316","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.jacc.2024.03.392","volume":"83","author":"S Chatur","year":"2024","unstructured":"Chatur S, Neuen BL, Claggett BL, Beldhuis IE, Mc Causland FR, Desai AS, Rouleau JL, Zile MR, Lefkowitz MP, Packer M, McMurray JJV, Solomon SD, Vaduganathan M (2024) Effects of sacubitril\/valsartan across the spectrum of renal impairment in patients with heart failure. J Am Coll Cardiol 83:2148\u20132159","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR317","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ejhf.2740","volume":"25","author":"DS-H Lin","year":"2023","unstructured":"Lin DS-H, Lin F-J, Lin Y-S, Lee J-K, Lin Y-H (2023) The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end-stage renal disease and heart failure. Eur J Heart Fail 25:98\u2013107","journal-title":"Eur J Heart Fail"},{"key":"10568_CR318","first-page":"507","volume":"23","author":"S Taheri","year":"2012","unstructured":"Taheri S, Mortazavi M, Pourmoghadas A, Seyrafian S, Alipour Z, Karimi S (2012) A prospective double-blind randomized placebo-controlled clinical trial to evaluate the safety and efficacy of spironolactone in patients with advanced congestive heart failure on continuous ambulatory peritoneal dialysis. Saudi J Kidney Dis Transpl 23:507\u2013512","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10568_CR319","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2023.08.026","volume":"82","author":"S Chatur","year":"2023","unstructured":"Chatur S, Vaduganathan M, Claggett BL, Mc Causland FR, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Sabatine MS, Kober L, Ponikowski P, Merkely B, Petersson M, Langkilde AM, McMurray JJV, Solomon SD (2023) Dapagliflozin in patients with heart failure and deterioration in renal function. J Am Coll Cardiol 82:1854\u20131863","journal-title":"J Am Coll Cardiol"},{"key":"10568_CR320","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.0000000000000196","volume":"18","author":"J Barreto","year":"2023","unstructured":"Barreto J, Borges C, Rodrigues TB, Jesus DC, Campos-Staffico AM, Nadruz W, Luiz da Costa J, Bueno de Oliveira R, Sposito AC (2023) Pharmacokinetic properties of dapagliflozin in hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol 18:1051\u20131058","journal-title":"Clin J Am Soc Nephrol"},{"key":"10568_CR321","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCULATIONAHA.120.051685","volume":"143","author":"F Zannad","year":"2021","unstructured":"Zannad F, Ferreira JP, Pocock SJ, Zeller C, Anker SD, Butler J, Filippatos G, Hauske SJ, Brueckmann M, Pfarr E, Schnee J, Wanner C, Packer M (2021) Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: insights from EMPEROR-reduced. Circulation 143:310\u2013321","journal-title":"Circulation"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10568-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10568-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10568-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:05:46Z","timestamp":1763154346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10568-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":321,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10568"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10568-1","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Pagnesi reports personal fees from Abbott Laboratories, AstraZeneca, Bayer,\u00a0Boehringer Ingelheim, Eli Lilly,\u00a0Novartis, Novo Nordisk, Roche Diagnostics, Viatris,\u00a0and Vifor Pharma, all outside the submitted work. Dr. Ambrosy has received relevant research support through grants to his institution from the National Heart, Lung, and Blood Institute (K23HL150159 and R01AG091005), the American Heart Association (2nd Century Early Faculty Independence Award), The Permanente Medical Group, Northern California Community Benefits Programs, Garfield Memorial Fund, Abbott Laboratories, Amarin Pharma, Inc., Bayer Pharma AG, Cordio Medical, Edwards Lifesciences LLC, Esperion Therapeutics, Inc., Merck, and Novartis and has been a consultant to Corstasis, Merck, Novo Nordisk, scPharma, and SQ Innovation. Dr. Biegus has received honoraria from Bayer, Boehringer Ingelheim, and AstraZeneca for lectures and from Alleviant Medical, Reprieve Cardiovascular, and WhiteSwell for participation in clinical trial advisory boards and is a member of the Editorial Board of ESC Heart Failure and Heart Failure Reviews. Dr. Butler has been a consultant at Abbott, Adaptyx, American Regent, Amgen, AskBio, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardiac Dimension, Cardior, CSL Vifor, CVRx, Cytokinetics, Daxor, Diastol, Edwards, Element Sciences, Faraday, Idorsia, Impulse Dynamics, Imbria, Innolife, Intellia, Inventiva, Levator, Lexicon, Eli Lilly, Mankind, Medtronic, Merck, New Amsterdam, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Pulnovo, Regeneron, Renibus, Reprieve, Roche, Rycarma, Saillent, Salamandra, Salubris, SC Pharma, SQ Innovation, Secretome, Sequanna, Transmural, TekkunLev, Tenex, Tricog, Ultromic, Vera, and Zoll. Dr. Mebazaa has received research contracts from 4TEEN4, Roche, Sphingotec, Abbott Diagnostics, and Windtree; consulting fees from Roche, Corteria, Adrenomed, Fire, and Johnson & Johnson; and honoraria for lectures from Merck, Novartis, Roche, and Bayer; is co-inventor of a patent owned by S-Form Pharma on combined therapies to treat dyspnoea; and is a committee member for the Secret-HF trial sponsored by the French Government, S-Form Pharma, 4TEEN4, Echosens, and Implicity. Dr. Sato has received honoraria or consulting fees from Otsuka, Novartis, BMS, Bayer, Terumo, Boehringer Ingelheim, Daiichi Sankyo, Ono, AstraZeneca, Roche, and Abiomed. Dr. Savarese reports grants and personal fees from CSL Vifor, Boehringer Ingelheim, AstraZeneca, Servier, Novartis, Cytokinetics, Pharmacosmos, Medtronic, Bayer, and personal fees from Roche, Abbott, Edwards Lifesciences, TEVA, Menarini, INTAS, GETZ, and Laboratori Guidotti, and grants from Boston Scientific and Merck, all outside the submitted work. All other authors report no relevant conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}